The synthesis of single enantiomers of mycobacterial ketomycolic acids containing cis-cyclopropanes

Article abstract of DOI:10.1016/j.tet.2009.09.099

We report the syntheses of a single enantiomer of an unprotected ketomycolic acids containing a cis-cyclopropane and of related hydroxy-mycolic acids.

Full text of DOI:10.1016/j.tet.2009.09.099

Tetrahedron 65 (2009) 10214–10229
Contents lists available at ScienceDirect
Tetrahedron
journal homepage: www.elsevier.com/locate/tet
The synthesis of single enantiomers of mycobacterial ketomycolic acids
containing cis-cyclopropanes
*
Gani Koza, Cornelia Theunissen, Juma’a R. Al Dulayymi, Mark S. Baird
School of Chemistry, Bangor University, Bangor, Gwynedd LL 57 2 UW, UK
a r t i c l e i n f o
a b s t r a c t
Article history:
We report the syntheses of a single enantiomer of an unprotected ketomycolic acids containing a
cis-cyclopropane and of related hydroxy-mycolic acids.
Received 24 June 2009
Received in revised form
10 September 2009
Ó 2009 Elsevier Ltd. All rights reserved.
Accepted 24 September 2009
Available online 30 September 2009
1. Introduction
The two stereocentres in the a and b-positions relative to the
carboxylic group have both been found to be in the R-configuration
for all the mycolic acids examined, irrespective of the other func-
tional groups.6–10 The presence of the hydroxyl group and the rel-
ative configuration between it and the alkyl chain has been
demonstrated to be capable of altering the film molecular pack-
ing.11,12 Moreover, the absolute configuration of these two chiral
centres is necessary for efficient recognition by T cells and the
generation of an immune response by the host organism against
pathogenic mycobacteria;13 the same is also true for the anti-
tumour properties of MA derivatives.14 There is evidence that the
methoxy and methyl groups of MAs 2 and 4 are S,S and that the
Mycolic acids (MAs), eg. 1–5 (Scheme 1), are major constituents
of the cell envelope of Mycobacterium tuberculosis and other
mycobacteria, some of which are pathogenic to animals and
humans.1–4 Their presence is thought to be linked to the resistance
of these organisms to many antibiotics and other chemo-thera-
peutic agents.5
1, X, Y = CH2
X
Y
2, X = Me, Y = OMe
(CH2)b
a
-methylketone of ketomycolates is S, though it is not clear
CH3(CH2)a
(CH2)cCHOHCHCOOH
CH3(CH2)d
whether the stereochemistry is important for biological effect.7,15
a = 15, 17, 18, 19
b = 10, 14, 16
The balance of a-MAs 1 and 3, methoxy- 2 and 4 and keto-MAs such
c = 11, 15, 17, 19, 21
d = 21, 23
as 5 is characteristic of specific bacteria;4,5 in each case, each type of
MA is present as a mixture of homologues. The chain lengths
of MAs depend on the rate of growth of the bacterium.16 In the case
of the keto-MAs, the balance of those containing a cis-cyclopropane
CH3
X
Y
(CH2)m
CH3(CH2)l
(CH2)nCHOHCHCOOH
(7) and an a-methyl-trans-cyclopropane (6) is highly dependent on
CH3(CH2)
3, X,Y = CH2
4, X = Me, Y = OMe
p
the mycobacterial strain; thus for M. tuberculosis Aoyama B the ratio
is 1:3.3 whereas for M. tuberculosis H37Ra it is 1:0.03.4 In the case of
M. tuberculosis, the exact role of each type in the pathogenesis of
disease remains to be confirmed, but the oxygenated MAs have
a particular influence on macrophage growth; strains lacking
ketomycolates have a reduced ability to grow within THP-1 cells.17
Moreover, the absence of keto and methoxymycolates leads
to attenuation of M. tuberculosis in mice; the vaccine strain Myco-
bacterium bovis BCG-Pasteur lacks methoxy-mycolates.18 Moreover
cyclopropane stereochemistry plays a key role in pathogenesis and
immuno-modulatory function; thus a mutant strain lacking the
ability to produce trans-cyclopropanes enhances the induced
macrophage inflammatory response.19 The stereochemistry was
(l, m, p are long alkyl chains)
CH3
H3C
CH3(CH2)l
O
5
(CH2)m
(CH2)nCHOHCHCOOH
CH3(CH2)p
Scheme 1.
* Corresponding author.
E-mail address: m.baird@bangor.ac.uk (M.S. Baird).
0040-4020/$ – see front matter Ó 2009 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tet.2009.09.099

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10215
shown to affect host innate immune responses both positively and
negatively. We have recently reported the synthesis of an -myco-
late of type 1,20,21 and of methoxymycolates of type 2 with either
absolute stereochemistry at the cis-cyclopropane or -methyl-
methoxy fragment.22 We have also reported the synthesis of mero-
mycolate fragments containing the -methyl-trans-cyclopropane
O
O
O
a
N
N
N
S
O
(i)-(iii)
(CH2)10
Br(CH2)10OH
a
b-
N
12
Ph
a
unit and provided evidence that the relative stereochemistry of
methyl and cyclopropane is as shown in 6, and that, at least in the
case of wax esters derived by enzymatic Baeyer–Villiger reaction of
keto-mycolates, the absolute stereochemistry of this sub-unit is also
as shown in 6.23 If 6 and 7 are produced through a common
intermediate derived by adding a methyl group from SAM to a cis-
alkene, the stereochemistry of the cis-cyclopropane can then be
inferred to be as shown in 7. We have briefly reported syntheses of
Scheme 4. (i) Trimethylacetyl chloride, pyridine, DMAP, rt, 18 h (85%); (ii) 1-phenyl-
1H-tetrazole-5-thiol, potassium carbonate, acetone, 18 h, rt (93%); (iii) ammonium
molybdate (VI) tetrahydrate, H2O2, THF, IMS, rt, 20 h (97%).
Reaction of either 10 or 11 with sulfone 12 and base in a modi-
fied Julia-Kocienski reaction25 led to a mixture of E/Z-alkenes which
was hydrogenated to give the chain extended esters 13 and 14
(Scheme 5).
protected ketomycolates containing both a-methyl-trans- and cis-
cyclopropane fragments, 6 and 7, that can be adjusted to produce
a variety of absolute stereochemistries and chain lengths. However,
deprotection of these led to epimerisation at the methyl-position
adjacent to the ketone.24
t
t
OSiMe2 Bu
OSiMe2 Bu
CH3(CH2)17
CH3(CH2)17
(CH2)17OR
(CH2)17OR
Me
13 (R= COCMe3) 15 (R = H)
Me
14 (R= COCMe3)
Scheme 5.
16 (R = H)
2. Results and discussion
These were each deprotected by reductive removal of the ester
group to give the corresponding alcohols 15 and 16 and then oxi-
dised to the corresponding aldehyde, 17 or 18 (Scheme 6).
We now report in full the synthesis of the three stereoisomers of
the cis-ketomycolic acid 7, having chain lengths matching those of
a significant component in many mycobacteria,4 and the depro-
tection of one of these to give a single enantiomer of free mycolic
acid with S-stereochemistry adjacent to the ketone (Scheme 2).
t
OSiMe2 Bu
t
OSiMe2 Bu
OAc
O
CH3(CH2)17
CH3(CH2)17
CO2CH3
(CH2)16CHO
(CH2)16CHO
CH3(CH2)17
(CH2)15
(CH2)17
(CH2)CH3
Me
Me
17
18
6
Scheme 6.
OAc
O
For the synthesis of stereoisomers of compound 7, the cis-cy-
clopropane was introduced as 1921–23 or its enantiomer.20–22 Con-
densation of 17 with 19 in a modified Julia-Kocienski reaction,25
followed by saturation of the derived E/Z alkene mixture using di-
imide, led to ester 20. Removal of the ester group reductively fol-
lowed by oxidation of the derived alcohol 21, led to aldehyde 22
(Scheme 7)
CO2CH3
CH3(CH2)17
(CH2)15
(CH2)18
(CH2)23CH3
7
Scheme 2.
The a
-methylketone was introduced through either 822 or its
enantiomer, 9.22 Protection of the secondary alcohol, deprotection
of the primary alcohol and then oxidation led to the two aldehydes,
10 and 11 (Scheme 3).
The sulfone 12 was prepared from 10-bromodecan-1-ol by
reaction with trimethylacetyl chloride, followed by 1-phenyl-1H-
tetrazole-5-thiol to give the corresponding thiane and then oxi-
dation (Scheme 4).
t
O
S
Bu Me2SiO
N
N
N
O
CH3(CH2)17
(CH2)16CHO
O
N
+
O
Me
Ph
19
(i),(ii)
17
t
Bu Me2SiO
O
CH3(CH2)17
(CH2)18
OH
OH
Me
O
20
CH3(CH2)17
CH3(CH2)17
(iii)
OH
(CH2)7OTHP
(CH2)7OTHP
t
Bu Me2SiO
t
Me
Bu Me2SiO
Me
9
O
8
CH3(CH2)17
CH3(CH2)17
(CH2)18
22
(CH2)18
(i)-(iii)
(i)-(iii)
(iv)
Me
Me
21
t
OSiMe2 Bu
t
OSiMe2 Bu
Scheme 7. (i) THF, LiN(SiMe3)2, ꢀ12 and ꢀ5 ꢁC; (ii) 2,4,6-tri-isopropylbenzene-
sulphonyl hydrazide, THF (70%, 2 steps); (iii) LAH, THF, 0 ꢁC (97%); (iv) PCC, CH2Cl2, rt,
2 h (100%).
CH3(CH2)17
CH3(CH2)17
(CH2)6CHO
10
(CH2)6CHO
11
Me
In the same way, 19 and the enantiomeric aldehyde 18 were
converted into the ester 23 and hence the alcohol 24 and aldehyde
25. The enantiomer of 19, compound 26 was reacted in the sameway
with 18 to give eventually the aldehyde 29 via 27 and 28 (Scheme 8).
Me
Scheme 3. (i) Imidazole, DMF, then TBDMSCl, rt, 18 h then 50 ꢁC, 5 h (84,88%); (ii)
pyridinium-p-toluenesulfonate, MeOH, THF (86, 94%); (iii) PCC, CH2Cl2 (97,97%) (first%
refers to 8–10, second to 9–11).

10216
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
t
t
t
Bu Me SiO
O
Bu Me2SiO
O
Bu Me2SiO
2
O
CH3(CH2)17
O
O
(CH2)18
(CH2)5
OMe
(CH )
OMe
O
2 5
O
Me
OH
O
O
(i)
23
34
35
(ii), (iii)
O
t
t
Bu Me2SiO
Bu Me2SiO
O
CH3(CH2)17
CH3(CH2)17
OH
O
t
(CH2)18
Bu Me SiO
(CH2)18
2
N
N
Me
Me
O
S
(CH2)5
OMe
)23CH3
N
(CH )
OMe
2 5
24
25
N
(CH2
O
Ph
O
(CH ) CH
2 23
3
N
N
t
Bu Me2SiO
S
O
(iv)-(vii)
37
O
36
N
O
N
CH3(CH2)17
(CH2)18
O
(viii)
S
O
Ph
Me
OAc
O
26
OAc
O
27
O
S
N
N
N
N
(CH2)5
OMe
N
(CH2)5
OMe
(CH2)23CH3
N
N
O
(CH2)23CH3
N
Ph
(ix)
t
t
Bu Me2SiO
Ph
Bu Me2SiO
39
38
OH
O
CH3(CH2)17
CH3(CH2)17
(CH2)18
(CH2)18
Scheme 10. (i) 2,6-Lutidine, OsO4 (2.5% in 2-methyl-2-propanol), then NaIO4, 1,4-di-
oxane, H2O, 25 ꢁC, 2 h; (ii) LiN(SiMe3)2, 5-(docosane-1-sulfonyl)-1-phenyl-1H-tetra-
zole, THF, argon, rt, 2.5 h (83%); (iii) IMS, EtOAc, Pd/C, H2 (98%); (iv) KOH,
THF:MeOH:H2O, 70 ꢁC, 3 h (90%); (v) PPh3, CH2Cl2, NBS, rt, 1.5 h (87%); (vi) 1-phenyl-
1H-tetrazole-5-thiol, K2CO3, acetone, 18 h, rt (97%); (vii) THF, AcOH, water, 2 M HCl, rt,
18 h (75%); (viii) Ac2O, pyridine, toluene, rt, 18 h (98%); (ix) ammonium molybdate,
H2O2, THF, IMS, rt, 20 h (97%).
Me
Me
28
29
Scheme 8.
R,R-2-Alkyl-3-hydroxy acids have been prepared before by
a number of methods including asymmetric reduction of the corre-
sponding ketone either chemically or enzymically.26–29 In this work
it was introduced bytwo different methods, both based on alkylation
of an R-3-hydroxy ester. In the first, already reported for a different
chain length,30 a cyclic sulfate 32 was prepared from the diol 31,
prepared by Sharpless asymmetric hydroxylation. The sulfate 32 was
reduced to the alcohol and esterified to produce 33 (Scheme 9).
H
(i)
OAc
O
BnO
(ii)
BnO
40
41
(iii)
OAc
O
(iv)
OH
O
BnO
OH
OH
O
O
BnO
OMe
42
(i)
43
O
O
O
(CH2)5
31
OMe
(CH2
)
OMe
O
5
Scheme 11. (i) Copper iodide, THF, argon, vinylmagnesium bromide, ꢀ75 to ꢀ40 ꢁC,
–40 to ꢀ30 ꢁC for 1 h, then ꢀ20 ꢁC, 15 min; (ii) Ac2O, pyridine, toluene, rt, 18 h (99%);
(iii) DMF, oxone, OsO4 (2.5% in 2-methyl-2-propanol), 32 ꢁC, 3 h (78%); (iv) conc.
H2SO4, MeOH, reflux, 3.5 h (78%).
O
OH
O
30
OH
(ii)
O
O
O
O
S
OMe
(CH2
)
5
(iii)
(CH2)5
OMe
O
HO
O
ButMe2SiO
O
O
33
O
O
32
(i)
BnO
OMe
Scheme 9. (i) (DHQD)2PHAL (1 mol %), K3Fe(CN)6 (3 mol equiv.), K2CO3 (3 mol equiv.),
OsO4 (4 mol %), MeSO2NH2 (1 mol equiv.), tBuOH, H2O (96%); (ii) 1-SOCl2,
(2 mol equiv.), CCl4, 2-NaIO4 (1.5 mol equiv.), RuCl3$H2O, (5 mol %), in CCl4, CH3CN. H2O
(90%); (iii) NaBH4 (1 mol equiv), N,N-Dimethylacetamide, then H2SO4, ether (78%).
BnO
OMe
44
45
O
The ester 33 was allylated in a Frater reaction,31 followed by
silylation of the alcohol to produce 34. This was then chain extended by
a method that has previously been reported for a homologue to give
diester 36 (see Supplementary information). The pivaloyl ester was
removed and the alcohol produced converted into the corresponding
bromide. Substitution of the bromine under standard conditions gave
the corresponding thiane. The silyl protecting group was then ex-
changed for an acetate and the thiane oxidised to sulfone 39. The Julia-
Kocienski reaction of this leading to the complete keto-mycolic acid is
described later (Scheme 10).
O
O
(ii), (iii)
N
S
(CH2)21CH3
N
ButMe2SiO
O
N
N
47
BnO
OMe
(CH2)23CH3
Ph
46
(iv)
ButMe2SiO
O
In the second approach to the enantiopure 3-hydroxyacid unit,
ring opening of the epoxide 4032–35 with vinylmagnesium bromide
followed by protection as the acetate gave 41, which was oxidised
and transformed to hydroxy-ester 43 (Scheme 11).
The hydroxy ester could then be allylated, again using the Frater
method. Introduction of the allyl group to give 44, then protection of
the secondary alcohol followed by oxidative cleavage of the alkene as
reported earlier for a homologue30 led to an aldehyde 45. Thiscould be
chain extended to 46usingthemethodreported(Scheme 12)earlier. 30
ButMe2SiO
O
(v)
O
OMe
(CH2)23CH3
HO
OMe
(CH2)23CH3
49
48
Scheme 12. (i) (a) imidazole, DMF, TBDMSCl (87%); (b) 2,6-Lutidine, OsO4 (2.5% in
2-methyl-2-propanol), NaIO4, 1,4-dioxane, water, 25 ꢁC, 2 h; (ii) 47, LiN(SiMe3)2, THF, rt,
3 h (83%); (iii) 10% Pd/C, THF/IMS, H2, 1 h (98%); (iv) 10% Pd/C, EtOAc, H2, 3 days (95%);
(v) PCC, CH2Cl2, 2 h (90%).

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10217
The sulfone 50 was prepared from 12-bromo-dodecanol by
standard methods. Compound 49 was subjected to a Julia-Kocienski
reaction using 50, followed by saturation of the derived E/Z-mixture
of alkenes to give the bromide 51. This was then converted into the
corresponding sulfone 52, again by standard methods (Scheme 13).
The R-methyl-R-hydroxy isomer 62 was prepared in a similar
fashion from compound 22, which was first converted into 58 via
a Julia-Kocienski reaction with 57 (prepared in an analogous
manner to 12, see Supplementary information) as shown below
(Scheme 16).
N
t
N
t
Bu Me2SiO
Bu Me2SiO
O
O
S
O
49, (i), (ii)
N
O
CH3(CH2)17
Br(CH2)12
(CH2)18
N
Br(CH2)14
OMe
(CH2)23CH3
22
CH3
O
S
Ph
51
N
50
O
N
N
(CH2)9
57
(i), (ii)
N
O
(iii), (iv)
(v), (vi)
Ph
t
Bu Me2SiO
O
S
OAc
O
CH3(CH2)17
O
N
(CH2)18
(CH2)10
N
58
(CH2)14
OMe
(CH2)23CH3
CH3
O
N
O
N
(iii), (iv)
52
Ph
t
Bu Me2SiO
Scheme 13. ; (i) LiN(SiMe3)2, 49, THF, rt 3 h (82%); (ii) H2, Pd/C, IMS, THF (92%); (iii)
1-phenyl-1H-tetrazole-5-thiol, K2CO3, acetone (86%); (iv) HF.pyridine, pyridine, THF, 45 ꢁC,
18 h (84%); (v) Ac2O, pyridine, toluene, rt, 18 h (83%); (vi) MCPBA, CH2Cl2, rt, 18 h (82%).
CH3(CH2)17
(CH2)18
(CH2)9CHO
59
CH3
A modified Julia-Kocienski reaction between the aldehyde 25 and
sulfone 52, followed by saturation of the E/Z-alkene mixture with di-
imide gave the protected hydroxymycolic acid 53 (R¼SiMe2But); the
silyl protecting groupwas then removed to give 53(R¼H)(Scheme14).
Scheme 16. (i) 57, LiN(SiMe3)2, THF, rt, 3 h (87%); (ii) 2,4,6-Tri-isopropylbenzene-
sulphonyl hydrazine (93%); (iii) LiAlH4/THF (69%); (iv) PCC, CH2Cl2, rt, 2 h (95%).
OR
OAc
O
Compound 59 was then coupled with 39 and base followed by
hydrogenation of the derived alkene to give 60. Deprotection to
61 then led to the third isomer of hydroxymycolic acid 62
(Scheme 17).
CH3(CH2)17
(CH2)18
(CH2)15
OMe
Me
Me
(CH2)23CH3
53
OH
OH
O
t
Bu Me2SiO
OAc
O
CH3(CH2)17
(i), (ii)
CH3(CH2)17
(CH2)18
(CH2)15
OH
(CH2)23CH3
(CH2)18
(CH2)15
OMe
59+ 39
(CH2)23CH3
CH3
54
Scheme 14.
60
(iii)
OH
OAc
O
CH3(CH2)17
(CH2)18
(CH2)15
OMe
This was deprotected to produce the free hydroxymycolic acid
54. In the same way the diastereoisomeric hydroxymycolic acid 56
was prepared from 29 and 52 via the protected species 55
(R¼SiMe2But) and 55 (R¼H) (Scheme 15).
CH3
(CH2)23CH3
61
(iv)
OH
OH
O
OR
CH3(CH2)17
OAc
O
(CH2)18
(CH2)15
OH
(CH2)23CH3
CH3(CH2)17
CH3
(CH2)18
(CH2)15
62
OMe
Scheme 17. (i) THF, LiN(SiMe3)2, rt, 2 h (56%); dipotassium azodicarb-oxylate, THF,
MeOH, AcOH (2.5 ml), rt, 2 h (88%); (iii) HF.pyridine, 17 h, 40 ꢁC (94%); (iv) LiOH, THF,
MeOH, H2O, 45 ꢁC, 18 h (61%).
Me
(CH2)23CH3
55
OH
OH
O
CH3(CH2)17
Although hydroxymycolic acids are not among the most com-
mon MAs that have been reported, there is increasing evidence for
their importance. They are thought to be on the bio-synthetic
pathway to methoxymycolic acids and ketomycolic acids,15,17,36 and
have been detected in Mycobacterium smegmatis, M. tuberculosis
and M. bovis BCG Pasteur and Glaxo.15,37
(CH2)18
(CH2)15
OH
(CH2)23CH3
Me
56
Scheme 15.

10218
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
The protected hydroxy-mycolic acids, 53, 55 and 61 were each
OTHP
OAc
O
oxidised to the corresponding ketones, 63, 64 and 65, respectively
(Scheme 18).
CH3(CH2)17
(CH2)15
(CH2)18
OMe
(CH2)23CH3
Me
68
O
OAc
O
CH3(CH2)17
(i)
(CH2)18
(CH2)15
OMe
63
Me
OTHP
(CH2)23CH3
O
OH
O
CH3(CH2)17
O
OAc
(CH2)18
(CH2)15
OH
(CH2)23CH3
69
CH3(CH2)17
Me
(CH2)15
(CH2)18
OMe
(CH2)23CH3
(ii)
Me
64
t
O
OTHP
Bu Me2SiO
O
OAc
O
CH3(CH2)17
CH3(CH2)17
(CH2)15
(CH2)18
OH
(CH2)23CH3
(CH2)18
(CH2)15
OMe
(CH2)23CH3
Me
Me
70
65
Scheme 18.
(iii), (iv)
t
Bu Me2SiO
O
O
These protected ketomycolic acids each showed mass ions in
MALDI MS that corresponded to the isotope pattern for one of the
components in a keto-mycolate fraction separated from mycolic
acids isolated from Mycobacterium avium.38,39 These were then
deprotected with lithium hydroxide in THF–methanol–water for
18 h at 45 ꢁC to give the corresponding free mycolic acid in each
CH3(CH2)17
(CH2)15
OH
(CH2)18
(CH2)23CH3
Me
71
(v)
case. The product from 63 showed an ½a D26
ꢂ
þ4.9 (c 1.02, CHCl3). In
O
HO
O
the same way, hydrolysis of 65 gave a product with identical
CH3(CH2)17
spectroscopic properties and an ½a D26
þ4.4 (c 0.70, CHCl3). On this
ꢂ
(CH2)15
(CH2)18
OH
basis, the hydrolysis conditions had caused the epimerization of the
methyl group adjacent to the carbonyl to give the same acid 66 in
each case (Scheme 19).
Me
(CH2)23CH3
72
Scheme 20. (i) LiOH, THF, MeOH, H2O, 45 ꢁC. 16 h (60%); (ii) imidazole, DMF, toluene,
TBDMSCl, DMAP, 70 ꢁC, 18 h; K2CO3, MeOH, THF, H2O, then KHSO4 to pH 2 (76%); (iii)
pyridinium-p-toluenesulfonate, THF, MeOH, H2O, 47 ꢁC, 7 h (60%); (iv) PCC, CH2Cl2, rt,
2 h (74%); (v) pyridine, THF, HF-pyridine, 13 h, 42 ꢁC (83%).
O
OH
OH
O
CH3(CH2)17
(CH2)15
(CH2)18
OH
Deprotection of the two esters using lithium hydroxide in THF–
methanol–water led to 69. This was protected as the silyl ether 70
by reaction with an excess of TBDMS–Cl in dmf–imidazole–
toluene, followed by reaction with potassium carbonate and
methanol. This reaction first produced a bis-silyl protected mol-
ecule; the silyl protection on the acid was hydrolysed in the sec-
ond stage of this process. Removal of the THP-group and oxidation
then gave the ketone 71; removal of the silyl group with HF.pyr-
idine complex gave the keto-acid 72. The specific rotation of 72
was þ7.34 (c¼0.79, CHCl3), [M]D þ92, in comparison to the epi-
Me
(CH2)23CH3
O
66
O
CH3(CH2)17
(CH2)15
(CH2)18
OH
Me
(CH2)23CH3
67
Scheme 19.
In the same way, 64 gave 67, ½a D23
ꢂ þ3.5 (c 0.59, CHCl3). Given
meric mixture 66 above (½a D26
þ4.4 (c 1.02, CHCl3)), indicating that
ꢂ
the small contribution of the cis-cyclopropane to the molecular
rotations for these compounds, the closeness of the specific ro-
tations for 66 and 67 is not unexpected. The hydrolysis was
studied under a number of chemical conditions but all led to es-
sentially complete epimerisation in the free ketomycolic acid. The
literature reports that removal of mycolic acids from cell material
by hydrolysis with base also leads to epimerisation.6,7,10,15 How-
ever, there are reports that by using an enzyme system, the free
keto-acid may be obtained without epimerisation.15 When en-
zyme induced hydrolysis was tested for the synthetic mycolic
acids 63 or 64, no formation of the free mycolic acid could be
observed and starting material was recovered. Instead, an alter-
native chemical approach was adopted. The TBDMS group of 53
(R¼SiMe2But) was selectively removed and the resulting alcohol
was re-protected as a mixture of diasteromeric tetrahydropyranyl
ethers 68 (Scheme 20).
under these conditions the epimerization of the carbon adjacent
to the ketone had not happened. This figure is in broad agreement
with that for a ketomycolate mixture of homologues from BCG
(containing around 1:10 trans-a-methyl-alkene to cis-alkene)
which shows an [M]D when not epimerised of þ77 and when
epimerised of þ42.15 It is also in general agreement with the sum
of the contributions of an S-
a
-methylketone unit ([M]D þ44) and
an R,R-hydroxy acid unit ([M]D þ40),15 assuming a very small
contribution from the cis-cyclopropane. All of the peaks identified
in the 13C NMR spectrum of 72 were also present in a mixture of
natural keto-mycolic acids from M. avium containing both cis- and
a
-methyl-trans-cyclopropanes.38 The mass spectrum gave a mo-
lecular ion corresponding to the mass of the major component of
the cis-cyclopropane containing keto-acid series in that natural
fraction.38,39

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10219
The work described above provides routes to cis-cyclopropane
containing keto- and hydroxy-mycolic acids with any absolute
a colourless oil, (8R,9R)-8-(tert-butyldimethylsilanyloxy)-9-methyl
heptacosan-1-ol (2.7 g, 86%), ½a D23
þ12.9 (c 1.39, CHCl3) {Found
ꢂ
stereoisomers at the
a
-methyl group or the cyclopropane. Experi-
(MþNa)þ: 563.5213, C34H72NaO2Si requires: 563.5194}. This
showed dH: 3.65 (2H, q, J 6.5 Hz), 3.50 (1H, dt, J 3.5, 6.0 Hz), 1.58
(2H, quintet, J 7.3 Hz), 1.49–1.14 (44H, m, v. br.), 1.08–1.01 (1H, m),
0.90–0.86 (12H, s and t, J 6.9 Hz), 0.80 (3H, d, J 6.6 Hz), 0.03 (3H,
s), 0.02 (3H, s); dC: 75.9, 63.1, 37.8, 33.5, 32.8, 32.4, 31.9, 30.0,
29.9, 29.7(v. br.), 29.68, 29.5, 29.4, 27.7, 26.0, 25.9, 25.7, 22.7, 18.2,
14.5, 14.1, ꢀ4.2, ꢀ4.4; nmax: 3321, 2925, 2854, 1464, 1379, 1253,
ments to delineate the differing biological effects of such stereo-
isomers will be described elsewhere.
3. Experimental section
3.1. General
1058 cmꢀ1
.
Chemicals used were obtained from commercial suppliers or
prepared from them by methods described. Solvents which had to
be dry, e.g. ether, tetrahydrofuran were dried over sodium wire.
Petrol was of boiling point 40–60 ꢁC. Reactions carried under inert
conditions, were carried out under a slow stream of nitrogen. Those
carried out at low temperatures were cooled using a bath of
methylated spirit with liquid nitrogen. Silica gel (Merck 7736) and
silica plates used for column and thin layer chromatography were
obtained from Aldrich. Organic solutions were dried over anhy-
drous magnesium sulfate. GLC was carried out on a Perkin–Elmer
Model 8410 on a capillary column (15 mꢃ0.53 mm). IR spectra
were carried out on a Perkin–Elmer 1600 F.T.IR spectrometer as
liquid films. NMR spectra were recorded on an Advance 500 spec-
3.1.4. (8S,9S)-8-(tert-Butyldimethylsilanyloxy)-9-methylheptacosan-
1-ol. (8S,9S)-8-(tert-Butyldimethylsilanyloxy)-9-methylheptacos-
an-1-ol (94%), a colourless oil, ½a D
ꢂ
23–12.5 (c 1.39, CHCl3) {Found
(MþNa)þ: 563.5195, C34H72NaO2Si requires: 563.5194}, which
showed an identical NMR spectrum to that above, was prepared in
the same way from tert-butyldimethyl{(1S,2S)-2-methyl-1-[7-
(tetrahydropyran-2-yloxy)heptyl]-eicosyloxy}silane.
3.1.5. (8R,9R)-8-(tert-Butyldimethylsilanyloxy)-9-methylheptacosanal
10. (8R,9R)-8-(tert-Butyldimethylsilanyl-oxy)-9-methylheptacosan-
1-ol (3.8 g, 7.04 mmol) in dichloromethane (70 ml) was added in
portions with stirring to PCC (3.8 g, 17.6 mmol) in dichloromethane
(160 ml). After 2 h, it was diluted with ether (250 ml), filtered
through silica and the solvent was evaporated. Chromatography
eluting with petrol/ether (3:1) gave a colourless oil, (8R,9R)-8-(tert-
butyldimethylsilanyl-oxy)-9-methylheptacosanal 10 (3.7 g, 97%),
trometer . [a] values were recorded in CHCl3 on a POLAAR 2001
D
Optical Activity polarimeter. Mass spectra were recorded on
a Bruker Microtof or MALDI TOF spectrometers. IMS is industrial
methylated spirit.
½
a 2D4
ꢂ
þ7.2 (c 1.10, CHCl3) {Found Mþ: 538.5131, C34H70O2Si requires:
3.1.1. tert-Butyldimethyl-{(1R,2R)-2-methyl-1-[7-(tetrahydropyran-
2-yloxy)heptyl]eicosyloxy}silane. Imidazole (1 g, 14.7 mmol) was
added to a stirred solution of (8R,9R)-alcohol 830 (3 g, 5.9 mmol)
in dry DMF (35 ml) at rt followed by the addition of tert-butyl-
dimethylsilylchloride (1.15 g, 7.65 mmol). After 18 h the reaction
was warmed to 50 ꢁC for 5 h, then quenched with water (200 ml)
and extracted with dichloromethane (3ꢃ75 ml). The combined
organic layers were washed with water (100 ml), dried and the
solvent evaporated. Chromatography eluting with petrol/ether
(5:1) gave a colourless oil, tert-butyldimethyl{(1R,2R)-2-methyl-1-
538.5145}. This showed dH: 9.77 (1H, t, J 1.6 Hz), 3.51–3.48 (1H, m),
2.43 (2H, dt, J 1.6, 7.3 Hz), 1.64 (2H, quintet, J 7.3 Hz), 1.48–1.20 (42H,
m, v. br), 1.09–1.01 (1H, m), 0.90–0.88 (12H, s and t, J 6.9 Hz), 0.80
(3H, d, J 6.6 Hz), 0.03 (3H, s), 0.02 (3H, s); dC: 202.9, 75.9, 37.8, 33.4,
32.4, 31.9, 30.0, 29.72(v. br.), 29.68, 29.39, 29.21, 27.7, 25.9, 25.8, 22.7,
21.1, 18.2, 14.5, 14.2, ꢀ4.2, ꢀ4.4; nmax: 2925, 2854, 1731, 1464, 1379,
1253, 1073 cmꢀ1
.
3.1.6. (8S,9S)-8-(tert-Butyldimethylsilanyloxy)-9-methyl-
heptacosanal 11. Aldehyde 11 (5.35 g, 97%), ½a D25
ꢂ
–8.5 (c 1.01,
[7-(tetrahydropyran-2-yloxy)heptyl]eicosyloxy}-silane
(3.1 g,
CHCl3) {Found (MþNa)þ: 561.5020, C34H70NaO2Si requires:
561.5037}, a colourless oil which showed an identical NMR
spectrum to that above, was prepared in the same way
from (8S,9S)-8-(tert-butyldimethyl-silanyloxy)-9-methylheptaco-
san-1-ol.
84%),
½
a 2D4
ꢂ
þ6.2 (c 1.42, CHCl3) {Found (MþNa)þ: 647.5761,
C39H80NaO3Si requires: 647.5769}. This showed dH: 4.58 (1H, br.t, J
2.9 Hz), 3.90–3.85 (1H, m), 3.74 (1H, dt, J 7.0, 9.8 Hz), 3.51–3.49
(2H, m), 3.38 (1H, dt, J 6.6, 9.5 Hz), 1.87–1.81 (1H, m), 1.75–1.70
(1H, m), 1.62–1.26 (50H, m, v. br.), 1.09–1.01 (1H, m), 0.89 (9H, s),
0.88 (3H, t, J 7.0 Hz), 0.80 (3H, d, J 6.6 Hz), 0.03 (3H, s), 0.02 (3H,
s); dC: 98.9, 75.9, 67.7, 62.3, 37 8, 33.5, 32.5, 31.9, 30.8, 30.0, 29.9,
29.8, 29.77, 29.71(v. br.), 29.7, 29.5, 29.4, 27.7, 26.2, 26.0, 22.7, 19.7,
18.2, 14.4, 14.1, ꢀ4.2, ꢀ4.4; nmax: 2825, 2853, 1464, 1253, 1079,
3.1.7. 2,2-Dimethylpropionic acid 10-(1-phenyl-1H-tetrazol-5-sulfo-
nyl)decyl ester 12.
1035, 836, 773 cmꢀ1
.
(i) Trimethylacetyl chloride (7.3 g, 60.8 mmol, 1.2 mol equiv) in
dichloromethane (25 ml) was added over 15 min with stirring to
10-bromodecan-1-ol (12 g, 50.6 mmol), dichloromethane
(80 ml), pyridine (8.2 ml, 101 mmol, 2 mol equiv) and 4-dime-
thylamino-pyridine (0.25 g, 2 mmol) at rt after 18 h, dil hydro-
chloric acid (150 ml) was added. The organic phase was washed
with dil hydrochloric acid (100 ml) and brine (2ꢃ200 ml), dried
and the solvent was evaporated. The residue was dissolved in
petrol (200 ml) and filtered through silica washed with petrol
(50 ml). The silica was washed with petrol/ether (1:1, 150 ml)
and the solvent was evaporated to give a colourless oil, 2,2-
dimethylpropionic acid 10-bromo-decyl ester (13.8 g, 85%)
{Found: C, 56.2; H, 9.2; C15H29BrO2 requires: C, 56.07; H, 9.10}.
This showed dH: 4.05 (2H, t, J 6.6 Hz), 3.41 (2H, t, J 7.0 Hz), 1.86
(2H, quintet, J 7.2 Hz), 1.62 (2H, quintet, J 6.9 Hz), 1.44–1.40 (2H,
m), 1.36–1.30 (10H, m), 1.20 (9H, s); dC: 178.6, 64.4, 38.7, 34.0,
32.8, 29.4, 29.3, 29.1, 28.7, 28.6, 28.1, 27.2, 25.9; nmax: 2930,
3.1.2. tert-Butyldimethyl-{(1S,2S)-2-methyl-1-[7-(tetrahydropyran-
2-yloxy)heptyl]eicosyloxy}silane. tert-Butyldimethyl{(1S,2S)-2-methyl-
1-[7-(tetrahydropyran-2-yloxy)heptyl]eicosyloxy}silane (7.50 g, 88%),
a colourless oil, ½a D
ꢂ
24 –7.5 (c 1.34, CHCl3) {Found (MþNa)þ: 647.5744,
C39H80NaO3Si requires: 647.5769}, which showed an identical NMR
spectrum to that above, was prepared in the same way from (8S,9S)-
9-methyl-1-(tetrahydropyran-2-yloxy)hepta-cosan-8-ol.22
3.1.3. (8R,9R)-8-(tert-Butyldimethylsilanyloxy)-9-methylheptacosan-
1-ol. Pyridinium-p-toluenesulfonate (0.73 g, 0.5 mol eq.) in methanol
(40 ml) was stirred with tert-butyldimethyl-{(1R,2R)-2-methyl-1-
[7-(tetrahydropyran-2-yloxy)-heptyl]eicosyloxy}silane (3.63 g, 5.8 mmol)
in THF (30 ml) at 40 ꢁC for 2.5 h. Satd aq sodium bicarbonate (10 ml)
and water (20 ml) were added and extracted with ether (3ꢃ25 ml).
The combined organic layers were dried and evaporated. Chro-
matography eluting with petrol/ether (5:1, 3:1, then 1:1) gave
2856, 1729, 1480, 1398, 1285, 1158 cmꢀ1
.

10220
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
(ii) 1-Phenyl-1H-tetrazol-5-thiol (5.75 g, 32.3 mmol), 2,2-dime-
thylpropionic acid 10-bromodecyl ester (10 g, 31.2 mmol),
anhydrous potassium carbonate (9.5 g, 65.4 mmol) and ac-
etone (160 ml) were vigorously stirred at rt for 18 h. Water
(1 L) was added and the mixture was extracted with
dichloromethane (1ꢃ150 ml, 2ꢃ25 ml). The combined or-
ganic phases were washed with brine (2ꢃ200 ml), dried and
evaporated. Chromatography eluting with petrol/ether
(7:2.5, then 1:1) gave a colourless oil, 2,2-dimethyl-pro-
pionic acid 10-(1-phenyl-1H-tetrazol-5-ylsulfanyl)decyl es-
ter (12.1 g, 93%) {Found (MþNa)þ: 441.2292, C22H34N4NaO2S
requires: 441.2295}. This showed dH: 7.61–7.54 (5H, m), 4.04
(2H, t, J 6.6 Hz), 3.40 (2H, t, J 7.4 Hz), 1.82 (2H, quintet, J
7.4 Hz), 1.62 (2H, quintet, J 6.9 Hz), 1.48–1.42 (2H, m), 1.33–
1.28 (10H, m), 1.20 (9H, s); dC: 178.6, 154.5, 133.8, 130.0,
129.7, 123.8, 64.4, 38.7, 33.3, 29.4, 29.3, 29.2, 29.1, 29.0,
28.6, 28.5, 27.2, 25.9; nmax: 2929, 2856, 1726, 1500, 1461,
31.9, 30.0, 29.9, 29.72 (v. br.), 29.68, 29.59, 29.55, 29.4, 29.3, 28.6,
27.7, 27.2, 26.0, 25.9, 22.7, 18.2, 14.4, 14.2, ꢀ4.2, ꢀ.4; nmax: 2923,
2854, 1733, 1464, 1155, 836 cmꢀ1
.
3.1.9. 2,2-Dimethylpropionic acid (18S,19S)-18-(tert-butyldimethylsi-
lanyloxy)-19-methylheptatriacontyl ester 14. 2,2-Dimethylpropionic
acid (18S,19S)-18-(tert-butyldimethylsilanyloxy)-19-methylhepta-
triacontyl ester 14 (97%) {Found (MþNa)þ: 787.7327, C49H100NaO3Si
requires: 787.7334}, was obtained as a colourless oil in the same
way from 12 and (8S,9S)-aldehyde 11. It showed an identical NMR
spectrum to that above, ½a D25
ꢀ4.8 (c 0.88, CHCl3).
ꢂ
3.1.10. (18R,19R)-18-(tert-Butyldimethylsilanyloxy)-19-methyl-hep-
tatriacontan-1-ol 15. Ester 13 was added over 15 min to a suspen-
sion of lithium aluminium hydride (0.37 g, 9.6 mmol) in THF
(60 ml) at ꢀ20 ꢁC under nitrogen. After refluxing the mixture for
1 h, satd aq sodium sulfate was added at ꢀ20 ꢁC until a precipitate
had formed. THF (60 ml) was added and the mixture was stirred at
rt for 30 min, filtered through silica and the solvent evaporated.
Chromatography eluting with petrol/ether (3:1, then 4:3) gave
1388, 1285, 1159 cmꢀ1
.
(iii) Ammonium molybdate (VI) tetrahydrate (13.9 g, 11.25 mmol)
in 35% H2O2 (37 ml), prepared and cooled in an ice bath, was
added with stirring to 2,2-dimethylpropionic acid 10-(1-phe-
nyl-1H-tetrazol-5-ylsulfanyl)decyl ester (10 g, 23.9 mmol) in
THF (140 ml) and IMS (280 ml) at 10 ꢁC. After 2 h at rt, further
ammonium molybdate (VI) tetrahydrate (7.5 g, 6.1 mmol) in
35% H2O2 (20 ml) was added. After 18 h, the mixture was
poured into water (1.2 L) and extracted with dichloromethane
(1ꢃ200 ml, 3ꢃ30 ml). The combined organic phases were
washed with water (500 ml), dried and evaporated. Chroma-
tography eluting with petrol/ether (3:1, then 1:1) gave a yellow
oil, 2,2-dimethylpropionic acid 10-(1-phenyl-1H-tetrazole-5-
sulfonyl)decyl ester 12 (10.5 g, 97%) {Found (MþNa)þ:
a
colourless oil, (18R,19R)-18-(tert-butyldimethylsilanyloxy)-19-
a 24
methylheptatriacontan-1-ol 15 (4.3 g, 98%), ½ ꢂD þ5.1 (c 0.95,
CHCl3) {Found (MþH)þ: 681.6921, C44H93O2Si requires: 681.6939}.
This showed dH: 3.65 (2H, q, J 6.7 Hz), 3.52–3.48 (1H, m), 1.58 (2H,
quintet, J 6.9 Hz), 1.48–1.12 (65H, m, v. br.), 1.08–1.01 (1H, m), 0.90–
0.88 (12H, m, including a singlet resonating at
d 0.89 for the tert-
butyl group), 0.80 (3H, d J 6.7 Hz), 0.03 (3H, s), 0.02 (3H, s); dC: 75.9,
63.1, 37.7, 33.5, 32.8, 32.4, 31.9, 30.0, 29.9, 29.7, 29.6(v. br.), 29.5,
29.4, 27.7, 26.0, 25.9, 25.8, 22.7, 18.2, 14.4, 14.2, ꢀ.2, ꢀ4.4; nmax
:
3330, 2927, 2848, 1465, 1378, 1253, 1058 cmꢀ1
.
473.2186, C22H34N4NaO4S requires: 473.2199}. This showed dH
:
3.1.11. (18S,19S)-18-(tert-Butyldimethylsilanyloxy)-19-methylhepta-
triacontan-1-ol 16. (18S,19S)-18-(tert-Butyldimethylsilanyloxy)-19-
methylheptatriacontan-1-ol 16 (95%), was obtained in the same
way from 2,2-dimethylpropionic acid (18S,19S)-18-(tert-butyl-
dimethylsilanyloxy)-19-methylheptatriacontyl ester as a colourless
7.1–7.69 (2H, m), 7.63–7.60 (3H, m), 4.04 (2H, t, J 6.6 Hz), 3.75–
3.72 (2H, m), 2.01–1.94 (2H, m), 1.62 (2H, quintet, J 6.9 Hz), 1.50
(2H, quintet, J 7.4 Hz),1.34–1.29 (10H, m),1.20 (9H, s); dC: 178.6,
153.4, 133.0, 131.4, 129.7, 125.0, 64.3, 55.9, 38.7, 29.3, 29.1, 29.0,
28.8, 28.5, 28.1, 27.2, 25.8, 21.9; nmax: 2930, 2857, 1725, 1498,
oil, ½a 2D4
ꢂ
–5.1 (c 1.02, CHCl3) {Found (MþH)þ: 681.6948, C44H93O2Si
1480, 1342, 1286, 1154 cmꢀ1
.
requires: 681.6939}. This showed an identical NMR spectrum to
that above.
3.1.8. 2,2-Dimethylpropionic acid (18R,19R)-18-(tert-butyldime-
thylsilanyloxy)-19-methylheptatriacontyl ester 13. Sulfone 12 (3.9 g,
8.7 mmol) was dissolved in dry THF (60 ml) and a solution of al-
dehyde 10 (3.8 g, 7.1 mmol) in dry THF (60 ml) was added at rt This
was cooled to –10 ꢁC and lithium bis(trimethylsilyl)amide (13 ml,
13.49 mmol, 1.9 mol equiv, 1.06 M) was added at ꢀ10 to ꢀ4 ꢁC, then
allowed to reach rt and stirred for 1.5 h. Ether (75 ml) and satd aq
ammonium chloride (25 ml) were added. The organic phase was
separated and the water layer was extracted with ether (2ꢃ75 ml).
The combined organic layers were dried and the solvent was
evaporated. Chromatography eluting with petrol/ether (10:0.6)
gave a colourless oil, 2,2-dimethylpropionic acid (E/Z)-(18R,19R)-
18-(tert-butyldimethylsilanyloxy)-19-methylheptatriacont-10-enyl
ester (4.9 g, 92%) as a 2.3:1 mixture of isomers {Found (MþNa)þ:
785.7205, C49H98NaO3Si requires: 785.7177}. Palladium 10% on
carbon (1.5 g) was added to a stirred solution of the above alkenes
(4.94 g, 6.5 mmol) in ethanol (150 ml) and ethyl acetate (70 ml).
Hydrogenation was carried out for 1 h. The solution was filtered
through Celite and evaporated to give a pure colourless oil, 2,2-
dimethylpropionic acid (18R,19R)-18-(tert-butyldimethylsilanyl-
3.1.12. (18R,19R)-18-(tert-Butyldimethylsilanyloxy)-19-methylhepta-
triacontanal 17. Alcohol 15 (2.0 g, 2.94 mmol) in dichloromethane
(30 ml) was added in portions to a stirred solution of PCC (1.6 g,
7.35 mmol, 2.5 mol equiv) in dichloromethane (120 ml) at rt After
2 h, it was diluted with ether (150 ml), filtered through silica and
the solvent evaporated. Chromatography eluting with petrol/ether
(4:1) gave a colourless oil, (18R, 19R)-18-(tert-butyldimethylsila-
nyloxy)-19-methylheptatriacontanal 17 (1.95 g, 98%), ½a D23
þ5.8 (c
ꢂ
0.92, CHCl3) {Found Mþ: 678.6723, C44H90O2Si requires: 678.6710}.
This showed dH: 9.77 (1H, t, J 1.6 Hz), 3.51–3.48 (1H, m), 2.42 (2H,
dt, J 1.6, 7.3 Hz), 1.64 (2H, quintet, J 7.3 Hz), 1.50–1.13 (62H, m, v. br.),
1.08–1.01 (1H, m), 0.90–0.88 (12H, m, including a s), 0.80 (3H, d, J
6.7 Hz), 0.03 (3H, s), 0.02 (3H, s); dC: 202.9, 75.9, 43.9, 37.7, 33.5,
32.5, 31.9, 30.0, 29.9 (v. br.), 29.65, 29.6, 29.5, 29.4, 29.2, 27.7, 26.0,
25.9, 22.7, 22.1, 18.2, 14.4, 14.1, ꢀ4.2, ꢀ4.4; nmax: 2925, 2854, 1731,
1465, 1379, 1253, 1072 cmꢀ1
.
3.1.13. (18S,19S)-18-(tert-Butyldimethylsilanyloxy)-19-methylhepta-
triacontanal18. Aldehyde 18 (5.00 g, 95%) ½a D23
ꢀ5.15 (c 0.95, CHCl3)
ꢂ
{Found (MþNa)þ: 701.6590, C44H90NaO2Si requires: 701.6602} was
prepared in the same way from alcohol 16 as a colourless oil. This
showed an identical NMR spectrum to that above.
oxy)-19-methylheptatriacontyl ester 13 (4.9 g, 99%), ½a D25
þ4.8 (c
ꢂ
1.10, CHCl3) {Found (MþNa)þ: 787.7355, C49H100NaO3Si requires:
787.7334}. This showed dH: 4.05 (2H, t, J 6.6 Hz), 3.51–3.48 (1H, m),
1.62 (2H, quintet, J 6.6 Hz), 1.49–1.26 (64H, m, v. br.), 1.20 (9H, s),
1.08–1.01 (1H, m), 0.90–0.87 (12H, m), 0.80 (3H, d, J 6.6 Hz), 0.03
(3H, s), 0.02 (3H, s); dC: 178.7, 75.9, 64.5, 38.7, 37.7, 33.5, 32.5(þ),
3.1.14. Butyric acid (1R,2S)-2-[(19R,20R)-19-(tert-butyldimethylsilanyl-
oxy)-20-methyloctatriacontyl]cyclopropylmethyl ester 20. Aldehyde 17
(1.87 g, 2.76 mmol) in dry THF (20 ml) was added with stirring to

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10221
butyric acid (1R,2S)-2-(1-phenyl-1H-tetrazole-5-sulfonylmethyl)-
cyclopropyl-methyl ester 1921–23 (1.2 g, 3.31 mmol) in dry THF
(20 ml) at rt, cooled to ꢀ10 ꢁC and lithium bis-(tri-methylsilyl)
amide (4.9 ml, 5.2 mmol, 1.06 M) was added at ꢀ12 to ꢀ5 ꢁC. After
1.5 h at rt, dichloromethane (60 ml) and satd aq ammonium chlo-
ride (50 ml) were added and extracted. The aqueous layer was re-
extracted with dichloromethane (2ꢃ30 ml), the combined organic
layers were washed with water (100 ml), dried and evaporated.
Chromatography eluting with petrol/ether (10:0.5) gave a colour-
less oil, butyric acid (1R,2S)-2-[(E/Z)-(19R, 20R)-19-(tert-butyldime-
thylsilanyloxy)-20-methyloctatriacont-1-enyl]cyclopropylmethyl ester
(2.05 g, 91%) as a 1.6:1 mixture of two isomers {Found (MþNa)þ:
839.7642, C53H104NaO3Si requires: 839.7647}. The above alkenes
(2.5 g, 3.06 mmol) and 2,4,6-tri-isopropylbenzenesulphonyl hy-
drazide (3.2 g, 10.7 mmol) were dissolved in dry THF (50 ml) and
stirred at 40 ꢁC for 3 h. Further TPBSH (1 g, 3.34 mmol) was added
and stirred at 40 ꢁC for 24 h. The mixture was diluted with petrol/
ether (1:1, 200 ml) and aq sodium hydroxide (80 ml, 2%) was added
and extracted. The aqueous layer was re-extracted with petrol/
ether (1:1, 2ꢃ60 ml) and the combined organic layers were washed
with water (80 ml), dried and evaporated. Chromatography eluting
with petrol/ether (25:1) gave a colourless oil containing a small
amount of alkene. The mixture was dissolved in dichloro-methane
(35 ml) and water (35 ml) then acetic acid (1 ml), cetrimide (0.15 g)
and potassium permanganate (0.7 g) were added and stirred at rt
for 1 h. Sodium metabisulfite was added until the dark colour dis-
appeared and the mixture was extracted with dichloromethane
(3ꢃ30 ml). The combined organic layers were dried, filtered and
evaporated. Chromatography eluting with petrol/ether (25:1) gave
a colourless oil, butyric acid (1R,2S)-2-[(19R,20R)-19-(tert-butyldi-
methylsilanyloxy)-20-methyloctatriacontyl]cyclopropylmethyl es-
portions to PCC (0.65 g, 3.0 mmol) stirred in dichloromethane
(100 ml) at rt After 2 h, it was diluted with ether (150 ml), filtered
through silica and the solvent was evaporated. Chromatography
eluting with petrol/ether (6:1) gave a colourless oil, (1R,2S)-2-
[(19R,20R)-19-(tert-butyldimethylsilanyloxy)-20-methyloctatriacont-
yl]cyclopropanecarbaldehyde22 (0.9 g,100%), ½a D25
þ7.6 (c1.19, CHCl3)
ꢂ
{Found (MþH)þ: 747.7397, C49H99O2Si requires: 747.7409}. This
showed dH: 9.36 (1H, d, J 5.7 Hz), 3.52–3.49 (1H, m),1.87 (1H, ddt, J 8.2,
5.7, 5.4 Hz), 1.62–1.56 (2H, m), 1.50–1.18 (71H, m, v. br.), 1.07–1.01 (1H,
m), 0.90–0.87 (12H, including a singlet at d 0.89), 0.80 (3H, d, J 6.7 Hz),
0.04(3H, s), 0.03(3H, s);dC: 201.7, 75.9, 37.7, 33.6, 32.5, 31.9, 30.0, 29.99,
29.9, 29.7(v. br.), 29.7, 29.67, 29.6, 29.5, 29.4, 29.3, 28.2, 27.8, 27.7, 26.0,
25.9, 24.8, 22.7,18.2,14.7,14.4,14.1, ꢀ4.2, ꢀ4.4; nmax: 2925, 2853,1706,
1465, 1253 cmꢀ1
.
3.1.17. Butyric acid (1R,2S)-2-[(19S,20S)-19-(tert-butyldimethylsila-
nyloxy)-20-methyloctatriacontyl]-cyclopropylmethyl ester 23. A so-
lution of (18S, 19S)-aldehyde 18 (1.8 g, 2.65 mmol) in dry THF (10 ml)
was added with stirring to sulfone 19 (1.26 g, 3.45 mmol) in dry THF
(20 ml) at rt, cooled to ꢀ5 ꢁC and lithium bis-(trimethyl-silyl)amide
(4.87 ml, 5.17 mmol, 1.06 M) was added at ꢀ5 ꢁC under nitrogen.
The solution was stirred for 1.5 h at rt. Work up as above gave a col-
ourless oil, butyric acid (1R,2S)-2-[(E/Z)-(19S,20S)-19-(tert-butyldi-
methylsilanyloxy)-20-methyloctatriacont-1-enyl]cyclopropylmethyl
ester (1.8 g, 83%) as a 2.5:1 mixture of isomers. The mixture (1.7 g,
7.28 mmol) and 2,4,6-tri-isopropylbenzenesulphonyl hydrazide
(2.17 g, 7.28 mmol) were stirred in dry THF (50 ml) at 40 ꢁC for 3 h.
Further TPBSH (1.5 g, 5.026 mmol) was added and stirred at 40 ꢁC
for 24 h. The mixture was worked up and purified as above to give
butyric acid (1R,2S)-2-[(19S,20S)-19-(tert-butyldimethylsilanyloxy)-
20-methyloctatriacontyl]cyclopropylmethyl ester 23 (1.35 g, 76%),
ter 20 (1.75 g, 70%), ½a D24
ꢂ
þ9.8 (c 1.26, CHCl3) {Found (MþNa)þ:
½
a 2D4
ꢂ
ꢀ0.78 (c 1.54, CHCl3) {Found (MþNa)þ: 841.7823, C53H106NaO3Si
841.7820, C53H106NaO3Si requires: 841.7803}. This showed dH: 4.20
(1H, dd, J 6.9, 11.7 Hz), 3.95 (1H, dd, J 8.5, 11.7 Hz), 3.51 (1H, dt, J 3.5,
6.3 Hz), 2.31 (2H, t, J 7.4 Hz), 1.68 (2H, sext, J 7.4 Hz), 1.50–1.13 (71H,
m, v. br.), 1.16–1.12 (1H, m), 1.08–1.01 (1H, m), 0.97 (3H, t, J 7.4 Hz),
0.91–0.88 (12H, s and t, J 6.9 Hz), 0.81 (3H, d, J 6.9 Hz), 0.75 (1H, dt, J
requires: 841.7803} as a colourless oil. This showed an essentially
identical NMR spectrum to that of its diastereomer 20 above.
3.1.18. {(1R,2S)-2-[(19S,20S)-19-(tert-Butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropyl}methanol 24. Ester 23 (1.3 g,
1.58 mmol) in dry THF (5 ml) was added dropwise over 15 min to
a suspension of lithium aluminium hydride (0.09 g, 2.38 mmol) in
THF (5 ml) at 0 ꢁC under nitrogen. The mixture was refluxed for 1 h.
Work up as above gave a colourless oil, {(1R,2S)-2-[(19S,20S)-19-
(tert-butyldimethylsilanyloxy)-20-methyloctatriacontyl]cyclo-
5.1, 8.5 Hz), 0.04 (3H, s), 0.03 (3H, s), 0.01 (1H, br. q, J 5.1 Hz); dC
:
173.8, 75.9, 65.1, 37.8, 36.4, 33.6, 32.5, 31.9, 30.0, 29.9, 29.7(v. br.),
29.6, 29.4, 28.6, 27.7, 26.0, 25.9, 22.7, 18.8, 18.2, 16.3, 14.4, 14.2, 14.1,
13.7, 9.8, ꢀ4.2, ꢀ4.4; nmax: 2924, 2854, 1739, 1665, 1252, 1181 cmꢀ1
.
3.1.15. {(1R,2S)-2-[(19R,20R)-19-(tert-Butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropyl}-methanol 21. Ester 20 (1.48 g,
1.81 mmol) in THF (10 ml) was added over 15 min to a suspension
of lithium aluminium hydride (0.17 g, 4.35 mmol) in THF (25 ml) at
0 ꢁC under nitrogen. The mixture was refluxed for 1 h, then cooled
to 0 ꢁC and satd aq sodium sulfate was added until a white
precipitate had formed. THF (50 ml) was added and the mixture
was stirred at rt for 30 min, filtered through silica and the solvent
was evaporated. Chromatography eluting with petrol/ether (4:3)
gave a colourless oil, {(1R,2S)-2-[(19R,20R)-19-(tert-butyldime-
thylsilanyloxy)-20-methyloctatriacontyl]cyclopropyl}methanol 21
propyl}methanol (1.12 g, 95%), ½a D22
ꢂ þ1.7 (c 1.02, CHCl3) {Found
(MþNa)þ: 771.7409, C49H100NaO2Si requires: 771.7385}, which
showed an essentially identical NMR spectrum to that of its di-
astereomer 21.
3.1.19. (1R,2S)-2-[(19S,20S)-19-(tert-Butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropanecarbaldehyde
25. A
solution
of {(1R,2S)-alcohol 24 (0.76 g, 1.02 mmol) in dichloromethane
(20 ml) was added in portions with stirring to PCC (0.66 g,
3.05 mmol) in dichloromethane (30 ml) at rt. After 2 h, work up as
above gave (1R,2S)-2-[(19S,20S)-19-(tert-butyldimethylsilanyloxy)-
20-methyloctatriacontyl]cyclopropanecarbaldehyde 25 (0.73 g,
(1.31 g, 97%), ½a D22
ꢂ
þ10.5 (c 0.89, CHCl3) {Found (MþNa)þ: 771.7363,
C49H100NaO2Si requires: 771.7385}. This showed dH: 3.66 (1H, dd, J
7, 11 Hz), 3.59 (1H, dd, J 8, 11 Hz), 3.52–3.48 (1H, m), 1.51–1.21 (71H,
m, v. br.), 1.15–1.0 (2H, m), 0.90–0.88 (12H, s and t, J 6.7 Hz), 0.80
(3H, d, J 6.6 Hz), 0.71 (1H, dt, J 4.4, 8.2 Hz), 0.04 (3H, s), 0.03 (3H, s),
ꢀ.03 (1H, br. q, J 5.4 Hz); dC: 75.9, 63.4, 37.7, 33.5, 32.5, 31.9, 30.2,
30.0, 29.9, 29.7(v. br.), 29.67, 29.65, 29.6, 29.4, 28.6, 27.7, 26.0, 25.9,
22.7, 18.2, 16.2, 14.4, 14.1, 9.5, ꢀ4.2, ꢀ4.4; nmax: 3346, 2924, 2853,
96%), as a colourless oil, ½a D25
ꢂ
ꢀ4.89 (c 0.92, CHCl3) {Found (MþNa)þ:
769.7195, C49H98NaO2Si requires: 769.7228}, which showed an
essentially identical NMR spectrum to that of its diastereomer 22.
3.1.20. Butyric acid (1S,2R)-2-[(19S,20S)-19-(tert-butyldimethylsilanyl-
oxy)-20-methyloctatriacontyl]cyclopropylmethyl ester 27. A solution
of (18S,19S)-aldehyde 18 (2.1 g, 3.09 mmol) in dry THF (10 ml) was
added with stirring to sulfone 26 (1.46 g, 4.02 mmol) in dry THF
(20 ml) at rt, cooled to ꢀ5 ꢁC and lithium bis-(trimethylsilyl) amide
(5.69 ml, 6.03 mmol, 1.06 M) was added. The solution was stirred for
1.5 h at rt when work up as above gave butyric acid (1S,2R)-2-[(E/Z)-
(19S,20S)-19-(tert-butyldimethylsilanyloxy)-20-methyloctatriacont-
1465, 1253, 1033 cmꢀ1
.
3.1.16. (1R,2S)-2-[(19R,20R)-19-(tert-Butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropane-carbaldehyde 22. A solution of
alcohol 21 (0.9 g, 1.2 mmol) in dichloromethane (25 ml) was added in

10222
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
1-enyl]cyclopropylmethyl ester (2.2 g, 87%) as a 1.6:1 mixture of
isomers. The mixture (2.0 g, 2.44 mmol) and 2,4,6-tri-iso-
propylbenzenesulphonyl hydrazide (2.55 g, 8.57 mmol) were stirred
in dry THF (50 ml) at 40 ꢁC for 3 h. Further TPBSH (1.5 g, 5.02 mmol)
was added and stirred at 40 ꢁC for 24 h. Work up and purification as
above gave butyric acid (1S,2R)-2-[(19S,20S)-19-(tert-butyldime-
thylsilanyloxy)-20-methyloctatriacontyl]cyclopropylmethyl ester 27
(14.75 g, 55.45 mmol) in methanol (300 ml) and refluxed for 3.5 h.
The methanol was evaporated and ethyl acetate (250 ml) and satd aq
NaHCO3 (200 ml) added. The aqueous layer was extracted with ethyl
acetate (2ꢃ150 ml) and the combined organic layers were dried and
evaporated. Chromatography eluting with petrol/ethyl acetate (3:2)
gave a colourless oil, (R)-5-benzyloxy-3-hydroxypentanoic acid
methyl ester 43 (10.23 g, 78%), ½a D26
ꢀ12.2 (c 1.23, CHCl3) {Found
ꢂ
(1.6 g, 80%), ½a 2D4
ꢂ
ꢀ8.8 (c 1.30, CHCl3) {Found (MþNa)þ: 841.7786,
(MþNa)þ: 261.1085, C13H18NaO4 requires: 261.1097}. This showed
dH: 7.37–7.28 (5H, m), 4.53 (2H, s), 4.26 (1H, tdd, J 6.3, 4.1, 7.9 Hz),
3.72 (1H, ddd, J 5.1, 6.3, 9.5 Hz), 3.71 (3H, s), 3.66 (1H, ddd, J 5.1, 6.9,
9.5 Hz), 3.38 (1H, d, J 3.2 Hz), 2.52 (2H, d, J 6.3 Hz),1.87–1.77 (2H, m);
dC: 172.8, 138.0, 128.4, 127.7, 127.6, 73.3, 68.0, 67.0, 51.7, 41.4, 36.0;
C53H106NaO3Si requires: 841.7803} as a colourless oil which showed
an identical NMR spectrum to that of 20 above.
3.1.21. {(1S,2R)-2-[(19S,20S)-19-(tert-Butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropyl}methanol 28. (1S,2R)-Ester 29
(1.4 g, 1.71 mmol) in dry THF (5 ml) was added over 15 min to
a suspension of lithium aluminium hydride (0.1 g, 2.63 mmol) in
THF (5 ml) at 0 ꢁC under nitrogen, then refluxed for 1 h. Work up as
above gave {(1S,2R)-2-[(19S,20S)-19-(tert-butyldimethylsilanyl-
oxy)-20-methyloctatriacontyl]cyclopropyl}methanol 28 (1.19 g,
nmax: 3467, 3031, 2951, 2864, 1737, 1496, 1438, 1168, 1100 cmꢀ1
.
3.1.26. (R)-2-((R)-3-Benzyloxy-1-hydroxypropyl)pent-4-enoic acid
methyl ester 44. Diisopropylamine (7.86 g, 77.69 mmol) was dis-
solved in dry THF (100 ml) and cooled to ꢀ78 ꢁC. MeLi (54.38 ml,
81.57 mmol,1.5 M) was added and stirred to þ16 ꢁC for 30 min then
re-cooled to ꢀ61 ꢁC and (R)-5-benzyloxy-3-hydroxypentanoic acid
methyl ester 43 (8.6 g, 36.13 mmol) in dry THF (50 ml) was added
and stirred at ꢀ45 ꢁC for 1 h, ꢀ20 ꢁC for 40 min and then at ꢀ20 to
ꢀ10 ꢁC for 20 min. It was re-cooled to ꢀ62 ꢁC and allyl iodide
(5.0 ml, 54.21 mmol) in dry THF (20 ml) and HMPA (12.57 ml,
72.27 mmol) was added and stirred at ꢀ45 ꢁC for 1 h., ꢀ45 to
ꢀ20 ꢁC for 30 min and then ꢀ20 ꢁC for 30 min. Further allyl iodide
(0.9 ml) was added and stirred at ꢀ20 to ꢀ10 ꢁC for 30 min and
then ꢀ10 ꢁC for 30 min. Satd aq ammonium chloride (70 ml) was
added and extracted with ether/ethyl acetate (1:1, 3ꢃ100 ml), dried
and the solvent evaporated. Chromatography eluting with petrol/
ethyl acetate (2:1) gave a colourless oil, (R)-2-((R)-3-benzyloxy-1-
hydroxypropyl)pent-4-enoic acid methyl ester 44 (7.64 g, 76%),
93%), ½a 2D2
ꢂ
ꢀ5.03 (c 2.68, CHCl3) {Found (MþNa)þ: 771.7348,
C49H100NaO2Si requires: 771.7385}, a colourless oil showing an
identical NMR spectrum to that of 21.
3.1.22. (1S,2R)-2-[(19S,20S)-19-(tert-Butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropanecarbaldehyde 29. {(1S,2R)-Alco-
hol 28 (1.01 g, 1.43 mmol) in dichloromethane (10 ml) was added in
portions to a stirred solution of PCC (0.92 g, 4.29 mmol) in
dichloromethane (50 ml) at rt. After 2 h, work up as above gave
(1S,2R)-2-[(19S,20S)-19-(tert-butyldimethylsilanyloxy)-20-methyl-
octatriacontyl]cyclopropanecarbaldehyde 29 (0.88 g, 82%), ½a D18
ꢂ
ꢀ12.00 (c 0.40, CHCl3) {Found (MþNa)þ: 769.7211, C49H98NaO2Si
requires: 769.7228}, as a colourless oil which showed an identical
NMR spectrum of 22 above.
½
a 2D1
ꢂ
ꢀ6.9 (c 1.09, CHCl3) {Found (MþH)þ: 279.1582, C16H23O4 re-
quires: 279.1591}. This showed dH: 7.38–7.28 (5H, m), 5.75 (1H, ddt,
J 17.0, 10.1, 6.9 Hz), 5.12–5.03 (2H, m), 4.52 (2H, s), 3.97 (1H, dtd, J
8.8, 5.7, 2.9 Hz), 3.72 (1H, ddd, J 4.8, 6.0, 9.2 Hz), 3.70 (3H, s), 3.66
(1H, ddd, J 5.1, 7.4, 9.5 Hz), 3.20 (1H, d, J 5.7 Hz), 2.58 (1H, td, J 5.7,
8.8 Hz), 2.47–2.35 (2H, m), 1.88–1.74 (2H, m); dC: 174.8, 137.9, 134.9,
3.1.23. Acetic
acid
(S)-1-(2-benzyloxyethyl)-but-3-enyl
ester
41. Acetic anhydride (80 ml) then anhydrous pyridine (80 ml) were
added with stirring to (S)-1-benzyloxyhex-5-en-3-ol (see Supple-
mentary data) (23.5 g, 114.1 mmol) in dry toluene (180 ml) at rt
After 18 h, it was diluted with toluene (100 ml) and the solvent was
evaporated. Chromatography eluting with petrol/ether (6:1) gave
a colourless oil, acetic acid (S)-1-(2-benzyloxyethyl)-but-3-enyl es-
128.4, 127.7, 127.6, 117.1, 73.3, 70.9, 68.3, 51.6, 51.0, 34.6, 33.3; nmax
:
.
3494, 3066, 3030, 2951, 2863,1735,1643,1438,1367,1170,1100 cmꢀ1
ter 41 (28.05 g, 99%), ½a D23
ꢂ
þ49.0 (c 1.13, CHCl3) {Found (MþH)þ:
3.1.27. (R)-2-[(R)-3-Benzyloxy-1-(tert-butyldimethylsilanyloxy)-
propyl]pent-4-enoic acid methyl ester. Imidazole (3.67 g,
249.1485, C15H21O3 requires: 249.1485}. This showed dH: 7.37–7.27
(5H, m), 5.76 (1H, ddt, J 17.0, 10.4, 7.0 Hz), 5.13–5.06 (3H, m), 4.50
(1H, d, J 12.0 Hz), 4.47 (1H, d, J 12.0 Hz), 3.54–3.46 (2H, m), 2.40–
2.30 (2H, m), 2.00 (3H, m), 1.94–1.82 (2H, m); dC: 170.6, 138.3, 133.5,
128.3, 127.7, 127.6, 117.8, 73.0, 70.8, 66.6, 38.8, 33.7, 21.1; nmax: 3066,
53.96 mmol) was added to a stirred solution of ester 44 (6.0 g,
21.83 mmol) in dry DMF (100 ml) at rt, followed by addition of tert-
butyldimethylchlorosilane (4.23 g, 28.06 mmol) and stirred at
45 ꢁC for 18 h. The mixture was quenched with water (350 ml) and
extracted with dichloromethane (3ꢃ200 ml). The combined or-
ganic layers were washed with water (200 ml), dried and the sol-
vent was evaporated. Chromatography eluting with petrol/ether
(4:1) gave a colourless oil, (R)-2-[(R)-3-benzyloxy-1-(tert-butyldi-
methylsilanyloxy)propyl]-pent-4-enoic acid methyl ester (7.4 g,
3031, 2923, 2861,1737,1643,1496,1454,1372,1241,1100,1026 cmꢀ1
.
3.1.24. (R)-3-Acetoxy-5-benzyloxypentanoic acid 42. Ester 41 (17.8 g,
71.77 mmol) was stirred in dry DMF (450 ml) and oxone (176.5 g,
287.1 mmol) then OsO4 2.5% in 2-methyl-2-propanol (9 ml,
0.72 mmol) were added at 10 ꢁC. The temperature was allowed to
reach 32 ꢁC for 3 h. The mixture was treated with water (3 L) and
extracted with ethyl acetate (1ꢃ500 ml, 2ꢃ250 ml). The combined
organic layers were washed with water (700 ml), dried and evapo-
rated. Chromatography eluting with petrol/ethyl acetate (1:1 then 1:2)
gave a colourless oil, (R)-3-acetoxy-5-benzyloxypentanoic acid 42
87%), ½a 2D6
ꢂ
ꢀ17.2 (c 0.93, CHCl3) {Found (MþNa)þ: 415.2256,
C22H36NaO4Si requires: 415.2275}. This showed dH: 7.37–7.27 (5H,
m), 5.73 (1H, ddt, J 17.0, 10.1, 6.9 Hz), 5.06–4.97 (2H, m), 4.49 (2H,
br.t, J 12.3 Hz), 4.13 (1H, br.q, J 5.7 Hz), 3.65 (3H, s), 3.59 (1H, td, J 6.3,
9.2 Hz), 3.55 (1H, td, J 6.6, 9.5 Hz), 2.69–2.65 (1H, m), 2.37–2.33 (2H,
m), 1.84–1.80 (2H, m), 0.87 (9H, s), 0.05 (6H, s); dC: 173.7, 138.5,
135.9, 128.3, 127.6, 127.5, 116.3, 72.9, 70.2, 66.3, 51.7, 51.3, 33.7, 31.3,
25.7,17.9, ꢀ4.4, ꢀ4.9; nmax: 3032, 2954, 2930, 2857,1739,1643,1437,
(14.85 g, 78%), ½a D22
ꢂ
þ15.2 (c 0.89, CHCl3) {Found (MþH)þ: 267.1216,
C14H19O5 requires: 267.1227}, dH: 7.37–7.27 (5H, m), 5.36 (1H, quintet, J
6.3 Hz), 4.49 (2H, br.t, J 12.5 Hz), 3.56 (1H, dt, J 15.8, 6.0 Hz), 3.53 (1H,
dt, J 16.1, 6.3 Hz), 2.71 (1H, dd, J 5.7, 15.8 Hz), 2.69 (1H, dd, J 6.9,
16.1 Hz), 2.01 (3H, s), 1.97 (2H, br.q, J 6.0 Hz); dC: 175.4, 170.4, 138.0,
128.4, 127.73, 127.66, 73.1, 68.2, 66.2, 38.9, 33.8, 21.0; nmax: 3457, 3064,
1361, 1254, 1171, 1100 cmꢀ1
.
3.1.28. (2R,3R)-5-Benzyloxy-3-(tert-butyldimethylsilanyloxy)-2-(2-
oxoethyl)pentanoic acid methyl ester 45. 2,6-Lutidine (2.36 g,
21.98 mmol), OsO4 2.5% in 2-methyl-2-propanol (2 ml, 0.2 mmol),
and then NaIO4 (9.4 g, 43.96 mmol) were added with stirring to the
above ester (4.0 g, 10.99 mmol) in 1,4-dioxane–water (160 ml, 3:1)
3032, 2930, 2864, 1740, 1680, 1454, 1374, 1242, 1176, 1100 cmꢀ1
.
3.1.25. (R)-5-Benzyloxy-3-hydroxypentanoic acid methyl ester
43. Conc. H2SO4 (70 drops) was added to a stirred solution of acid 42

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10223
at rt. The reaction was stirred at 25 ꢁC for 2 h, when water (300 ml)
and dichloromethane (300 ml) were added. The water layer was
extracted with dichloromethane (2ꢃ100 ml) and the combined
organic layers were washed with brine (200 ml), dried and
evaporated. Chromatography eluting with petrol/ether (2:1) gave
a colourless oil, (2R,3R)-5-benzyloxy-3-(tert-butyldimethylsilanyl-
oxy)-2-(2-oxoethyl)pentanoic acid methyl ester 45 (3.52 g, 88%),
dichloromethane (50 ml) was added in portions at rt to a stirred
solution of PCC (6.50 g, 30.15 mmol) in dichloromethane (400 ml).
After 2 h, ether (300 ml) was added and filtered through silica. The
solvent was evaporated. Chromatography eluting with petrol/ether
(4:1) gave a colourless oil, (R)-2-[(R)-1-(tert-butyldimethylsilanyl-
oxy)-3-oxopropyl]hexacosanoic acid methyl ester 49 (6.48 g, 90%),
½
a 2D8
ꢂ
ꢀ4.42 (c 1.29, CHCl3) {Found [MþH]þ: 597.5245, C36H73O4Si
½
a 2D6
ꢂ
ꢀ18.4 (c 0.97, CHCl3) {Found (MþH)þ: 395.2244, C21H35O5Si
requires: 597.5273}. This showed dH: 9.81 (1H, dd, J 1.6, 2.7 Hz), 4.43
(1H, dt, J 4.7, 6.0 Hz), 3.69 (3H, s), 2.66 (1H, ddd, J 1.6, 4.7, 6.3 Hz), 2.61
(1H, ddd, J 2.7, 6.3, 8.8 Hz), 2.59 (1H, ddd, J 4.1, 6.3, 10.4 Hz), 1.61–1.26
(46H, m, v. br.), 0.90 (3H, t, J 6.6 Hz), 0.86 (9H, s), 0.08 (3H, s), 0.07
(3H, s); dC: 201.3, 174.0, 68.8, 52.3, 51.5, 48.1, 31.9, 29.7(v. br.), 29.66,
29.62, 29.54, 29.5, 29.4, 29.3, 27.8, 27.0, 25.6, 22.7,17.9,14.1, ꢀ4.6, ꢀ4.9;
requires: 395.2248}. This showed dH: 9.81 (1H, s), 7.37–7.28 (5H, m),
4.50 (1H, d, J 12.0 Hz), 4.45 (1H, d, J 12.0 Hz), 4.27 (1H, td, J 4.4,
7.9 Hz), 3.68 (3H, s), 3.54–3.50 (2H, m), 3.23 (1H, ddd, J 3.2, 7.6,
10.4 Hz), 2.97 (1H, ddd, J 1.0, 10.4, 18.3 Hz), 2.70 (1H, dd, J 3.2,
18.3 Hz), 1.71–1.63 (2H, m), 0.87 (9H, m), 0.08 (3H, s), 0.07 (3H, s);
dC: 200.4, 172.4, 138.3, 128.3, 127.6, 127.5, 72.8, 68.8, 66.5, 52.0, 45.3,
40.0, 33.7, 25.7, 17.9, ꢀ4.7, ꢀ4.9; nmax: 3031, 2954, 2930, 2857, 1736,
nmax: 2925, 2854, 1736, 1465, 1362, 1255, 1196, 1168, 1098 cmꢀ1
.
1496, 1437, 1315, 1254, 1100 cmꢀ1
.
3.1.32. (R)-2-[(R)-15-Bromo-1-(tert-butyldimethylsilanyloxy)-
pentadecyl]hexacosanoic acid methyl ester 51. Lithium bis(tri-
methylsilyl)amide (11.32 ml, 12.00 mmol) was added to a stirred
solution of ester 49 (3.50 g, 6.15 mmol) and sulfone 50 (4.22 g,
9.23 mmol) (see Supplementary data) in dry THF (100 ml) at ꢀ12 ꢁC
under nitrogen. The reaction was stirred at rt for 3 h then quenched
with satd aq ammonium chloride (100 ml), extracted with petrol/
ether (1:1, 3ꢃ150 ml), dried and the solvent evaporated. Chroma-
tography eluting with petrol/ether (10:1) gave a colourless oil,
(R)-2-[(E/Z)-(R)-15-bromo-1-(tert-butyldimethylsilanyloxy)penta-
dec-3-enyl]hexacosanoic acid methyl ester (4.19 g, 82%), as a 2:1
mixture of two isomers. Palladium 10% on carbon (1 g) was added to
a stirred solution of the above alkenes (4.19 g, 5.06 mmol) in THF
(50 ml) and ethanol (50 ml). Hydrogenation was carried out 3 h. The
solution was filtered through Celite and the solvent was evaporated.
Chromatography eluting with petrol/ether (20:1) gave a colourless
oil, (R)-2-[(R)-15-bromo-1-(tert-butyldimethylsilanyloxy)pentadec-
3.1.29. (R)-2-[(R)-3-Benzyloxy-1-(tert-butyldimethylsilanyloxy)-
propyl]hexacosanoic acid methyl ester 46. Lithium bis(trimethyl-
silyl)amide (23.16 ml, 24.54 mmol) was added with stirring to ester
45 (4.39 g, 11.14 mmol) and 5-(docosane-1-sulfonyl)-1-phenyl-1H-
tetrazole 47 (see Supplementary data, 8.48 g,16.36 mmol) in dry THF
(150 ml) at ꢀ8 ꢁC under argon. After 3 h at rt, it was quenched with
satd aq ammonium chloride (120 ml), extracted with petrol/ether
(3ꢃ150 ml, 10:1), dried and the solvent was evaporated.
Chromatography eluting with petrol/ether (20:1) gave a colourless
oil, (E/Z)-(R)-2-[(R)-3-benzyloxy-1-(tert-butyldimethylsilanyloxy)-
propyl]tetracos-4-enoic acid methyl ester (R)-2-[(R)-3-benzyloxy-1-
(tert-butyldimethylsilanyloxy)propyl]hexacos-4-enoic acid methyl
ester (6.43 g, 83%) as a mixture of two isomers in ratio 2:1. Palladium
10% on carbon (0.3 g) was added to a stirred solution of the above
alkenes (6.43 g, 9.36 mmol) in THF/IMS (100 ml, 1:1). Hydrogenation
was carried out for 1 h. The solution was filtered through Celite and
evaporated. The product was purified by chromatography eluting
with petrol/ether (20:1) to give a colourless oil, (R)-2-[(R)-3-
benzyloxy-1-(tert-butyl-dimethylsilanyloxy)propyl]hexacosanoic acid
yl]hexacosanoic acid methyl ester 51 (3.88 g, 92%), ½a D26
ꢀ7.2 (c 0.68,
ꢂ
CHCl3) {Found (MþNa)þ: 851.6275, C48H97BrNaO3Si requires:
851.6283}. This showed dH: 3.92–3.90 (1H, m), 3.66 (3H, s), 3.41 (2H,
t, J 6.9 Hz), 2.53 (1H, ddd, J 3.8, 7.0, 10.7 Hz), 1.86 (2H, quintet, J
6.9 Hz), 1.59–1.54 (2H, m), 1.53–1.35 (7H, m), 1.34–1.10 (61H, m),
methyl ester 46 (6.30 g, 98%), ½a D28
ꢀ6.20 (c 0.79, CHCl3) {Found
ꢂ
(MþNa)þ: 711.5701, C43H80NaO4Si requires: 711.5718} as a colourless
oil. This showed dH: 7.37–7.27 (5H, m), 4.50 (2H, s), 4.10 (1H, br.q,
J 5.1 Hz), 3.67 (3H, s), 3.58–3.54 (2H, m), 2.55 (1H, ddd, J 3.8, 6.6,
10.4 Hz), 1.80 (2H, br.q, J 6.6 Hz), 1.66–1.16 (46H, m, v. br.), 0.89 (3H, t,
J 7.0 Hz), 0.86 (9H, s), 0.05 (3H, s), 0.04 (3H, s); dC: 174.7, 138.5, 128.3,
127.6, 127.5, 72.9, 70.7, 66.2, 52.0, 51.3, 33.7, 31.9, 29.7(v. br.), 29.65,
0.87–0.76 (12H, including a triplet at
d 0.89, J 6.9 Hz and a singlet at
d
0.87), 0.05 (3H, s), 0.03 (3H, s); dC: 175.1, 73.2, 51.5, 51.9, 33.9, 33.6,
32.8, 31.9, 29.8, 29.7, 29.6, 29.4, 29.37, 28.8, 28.2, 27.2, 27.5, 25.7, 23.6,
22.7, 19.4, 18.0, 14.1, ꢀ4.4, ꢀ4.9, nmax: 2924, 2854, 1741, 1464,
1361,1254, 1194, 1167, 1075, 836 cmꢀ1
.
29.58, 29.45, 29.36, 27.9, 27.2, 25.7, 22.7, 17.9, 14.1, ꢀ4.6, ꢀ4.9; nmax
:
3.1.33. (R)-2-[(R)-1-(tert-Butyldimethylsilanyloxy)-15-(5-phenyl-5H-
tetrazol-1-ylsulfanyl)pentadecyl]hexacosanoic acid methyl ester. Ester
51 (3.80 g, 4.58 mmol), anhydrous potassium carbonate (1.33 g,
9.61 mmol) and acetone (100 ml) were stirred vigorously for 18 h at
rt. Water (200 ml) was added and the mixture was extracted with
dichloromethane (1ꢃ200 ml, 2ꢃ100 ml). The combined organic
phases were washed with brine (2ꢃ200 ml), dried and evaporated.
Chromatography eluting with petrol/ether (4:1) gave a colourless
oil, (R)-2-[(R)-1-(tert-butyldimethylsilanyloxy)-15-(5-phenyl-5H-
tetrazol-1-ylsulfanyl)pentadecyl]hexacosanoic acid methyl ester
2925, 2854, 1740, 1664, 1464, 1361, 1254, 1195, 1168, 1102 cmꢀ1
.
3.1.30. (R)-2-[(R)-1-(tert-Butyldimethylsilanyloxy)-3-hydroxypropyl]
hexacosanoic acid methyl ester 48. Palladium 10% on carbon (1.5 g)
was added to a stirred solution of (R)-2-[(R)-3-benzyloxy-1-(tert-
butyldimethylsilanyloxy)propyl]tetracosanoic acid methyl ester 46
(13.55 g, 19.72 mmol) in ethyl acetate (100 ml) and hydrogenated for
3 days. The solution was filtered through Celite and the evaporated.
Chromatography eluting with petrol/ether (2:1) gave a white solid,
(R)-2-[(R)-1-(tert-butyldimethylsilanyloxy)-3-hydroxypropyl]hexaco
(3.64 g, 86%), ½a D26
ꢂ
ꢀ5.9 (c 0.91, CHCl3) {Found (MþNa)þ: 949.7295,
sanoic acid methyl ester 48 (11.18 g, 95%), mp 35–37 ꢁC, ½a D
ꢂ
22 –0.97 (c
C55H102N4NaO3SSi requires: 949.7334}. This showed dH: 7.61–7.52
(5H, m), 3.93–3.89 (1H, m), 3.66 (3H, s), 3.40 (2H, t, J 7.3 Hz), 2.53
(1H, ddd, J 10.7, 6.9, 3.5 Hz), 1.83 (2H, quintet, J 7.6 Hz), 1.65–1.11
0.86, CHCl3) {Found (MþNa)þ: 621.5220, C36H74NaO4Si requires:
621.5249}. This showed dH: 4.15–4.12 (1H, m), 3.83–3.72 (2H, m), 3.70
(3H, s), 2.64 (1H, ddd, J 3.8, 6.3,10.1 Hz), 1.90 (1H, br s), 1.80–1.74 (2H,
m), 1.64–1.45 (10H, m), 1.35–1.12 (36H, m), 0.91–0.87 (12H, m, in-
(70H, m), 0.93–0.82 (12H, m, including a triplet at
d 0.89, J 6.7 Hz,
and a singlet at 0.87), 0.04 (3H, s), 0.02 (3H, s); dC: 175.1, 154.5,
d
cluding a singlet at
59.53, 51.6, 51.0, 36.2, 32.4, 30.2(v. br.), 30.16, 30.15, 30.13, 30.1, 29.9,
d
0.88), 0.11 (3H, s), 0.07 (3H, s); dC: 174.7, 72.1,
133.7, 130.0, 129.7, 123.8, 73.1, 51.5, 51.2, 33.6, 33.3, 31.9, 29.8, 29.7
(v. br.), 29.6, 29.4, 29.3, 29.0, 28.8, 28.2, 27.8, 27.5, 25.7, 23.6, 22.7,
17.9, 14.1, ꢀ4.4, ꢀ5.0; vmax: 2924, 2854, 1739, 1599, 1501, 1464, 1386,
29.8, 28.5, 27.6, 26.0, 23.1, 18.2, 14.4, ꢀ4.4, ꢀ4.7; nmax: 3449, 2924,
2854, 1741, 1465, 1361, 1255, 1196, 1167, 1094 cmꢀ1
.
1250, 1167, 1074, 837, 776, 760, 694 cmꢀ1
.
3.1.31. (R)-2-[(R)-1-(tert-Butyldimethylsilanyloxy)-3-oxopropyl]hexa-
3.1.34. (R)-2-[(R)-1-Hydroxy-15-(5-phenyl-5H-tetrazol-1-ylsulfa-
cosanoic acid methyl ester 49. Ester 48 (7.20 g, 12.06 mmol) in
nyl)pentadecyl]hexacosanoic acid methyl ester. The above ester

10224
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
(3.64 g, 3.93 mmol) was dissolved in dry THF (25 ml) in a dry
polyethylene vial under argon at rt and stirred. Pyridine (1.5 ml)
and HF.pyridine (3 ml) were added and the mixture was stirred for
17 h at 45 ꢁC. The reaction was diluted with petrol/ether (1:1,
100 ml) and neutralized by pouring into satd aq NaHCO3 until no
more carbon dioxide was liberated. The mixture was extracted and
the aqueous layer was re-extracted with petrol/ether (1:1,
2ꢃ100 ml). The combined organic layers were washed with brine,
dried and evaporated. Chromatography eluting with petrol/ether
(5:2) gave a white solid, (R)-2-[(R)-1-hydroxy-15-(5-phenyl-5H-tet-
razol-1-ylsulfanyl)pentadecyl]hexacosanoic acid methyl ester
2498, 1739, 1593, 1499, 1470, 1407, 1374, 1348, 1303, 1245, 1137,
1099, 1022 cmꢀ1
.
3.1.37. (R)-2-((R)-1-Acetoxy-16-{(1R,2S)-2-[(19S,20S)-19-(tert-
butyldimethylsilanyl oxy) -20-methyloctatria-contyl]-
cyclopropyl}octadecyl)hexacosanoic acid methyl ester 53
(R¼SiMe2But). Ester 52 (0.82 g, 0.92 mmol) was dissolved in dry
THF (15 ml) and a solution of aldehyde 25 (0.69 g, 0.92 mmol) in
dry THF (10 ml) was added at rt. This solution was cooled to
ꢀ12 ꢁC and lithium bis-(trimethylsilyl) amide (1.4 ml,
1.48 mmol, 1.06 M) was added. The solution was allowed to
reach rt and stirred for 2 h. Ether (25 ml) and satd aq ammo-
nium chloride (30 ml) were added. The organic phase was
separated and the water layer was washed with petrol/ether
(20:1, 3ꢃ100 ml). The combined organic layers were dried and the
solvent was evaporated. Chromatography eluting with petrol/ether
(20:1) gave a colourless oil, (R)-2-((R)-1-acetoxy-16-{(1R,2S)-
2-[(19S,20S)-19-(tert-butyldimethylsilanyloxy)-20-methyloctatri-
acontyl]cyclopropyl}hexadec-15-enyl)-hexacosanoic acid methyl
ester (0.94 g, 72%) as a 4:1 mixture of isomers. Dipotassium
azodicarboxylate (2.0 g, 10.31 mmol) was added to a stirred
solution of the above alkenes (870 mg, 0.62 mmol) in THF
(25 ml) and methanol (5 ml) at 5 ꢁC. Half of a solution of glacial
acetic acid (5 ml) and THF (2 ml) was added dropwise at 5 ꢁC.
The mixture was stirred at rt for 2 h, then the other half was
then added and stirred overnight. Dipotassium azodicarboxy-
late (2.0 g) and then glacial acetic acid (5 ml) were added and
stirred overnight. This mixture was added slowly to satd aq
ammonium chloride, extracted with petrol/ether (1:1, 3ꢃ80 ml,)
and the combined organic layers were washed with water (50 ml)
and evaporated. The procedure was repeated. Chromatography
eluting with petrol/ether (20:1) gave a white semi-solid, (R)-2-
((R)-1-acetoxy-16-{(1R,2S)-2-[(19S,20S)-19-(tert-butyldimethyl-
silanyloxy)-20-methyloctatriacontyl]-cyclopropyl}octadecyl)hexa-
(2.70 g, 84%), ½a D16
ꢂ
þ3.4 (c 1.15, CHCl3), mp 63–65 ꢁC {Found
(MþNa)þ: 835.6437, C49H88N4O3SNa requires: 835.6469}. This
showed dH: 7.61–7.52 (5H, m), 3.71 (3H, s), 3.69–3.63 (1H, br m), 3.40
(2H, t, J 7.6 Hz,), 2.44 (2H, dt, J 5.4, 8.8 Hz), 1.82 (2H, quintet, J 7.3 Hz),
1.75–1.68 (1H, m), 1.62–1.55 (1H, m), 1.51–1.38 (5H, m), 1.36–1.10
(63H, br m) 0.88 (3H, t, J 6.6 Hz); dC: 176.2, 154.5, 133.7, 130.0, 129.7,
123.8, 72.3, 51.5, 50.9, 35.7, 33.3, 31.9, 29.7(v. br.), 29.6, 29.54, 29.5,
29.4, 29.3, 29.0, 28.99, 28.6, 27.4, 25.7, 22.7, 14.1; nmax: 3490, 2919,
1719, 1597, 1501, 1464, 1378, 1295, 1280, 1240, 1191, 1178, 1132 cmꢀ1
.
3.1.35. (R)-2-[(R)-1-Acetoxy-15-(5-phenyl-5H-tetrazol-1-ylsulfanyl)-
pentadecyl]hexacosanoic acid methyl ester. A mixture of acetic
anhydride (34 ml) and anhydrous pyridine (34 ml) was added to
a stirred solution of the (R)-2-[(R)-1-hydroxy-15-(5-phenyl-5H-
tetrazol-1-yl-sulfanyl)pentadecyl]hexacosanoic acid methyl ester
(2.63 g, 3.25 mmol) in dry toluene (80 ml) at rt. After 18 h, it was
diluted with toluene (40 ml) and the solvent was evaporated under
reduced pressure to give a solid. Chromatography eluting with
petrol/ether (5:1) gave a white solid, (R)-2-[(R)-1-acetoxy-15-(5-
phenyl-5H-tetrazol-1-ylsulfanyl)pentadecyl]hexacosanoic acid
methyl ester (2.31 g, 83%), ½a D17
þ6.6 (c 1.20, CHCl3), mp 51–
ꢂ
53 ꢁC {Found (MþNa)þ: 877.6554, C51H90N4O4SNa requires:
877.6575}. This showed dH: 7.61–7.52 (5H, m), 5.09 (1H, ddd, J
3.8, 7.0, 10.8 Hz), 3.68 (3H, s), 3.40 (2H, t, J 7.6 Hz), 2.62 (1H, ddd,
J 4.4, 7.0, 10.7 Hz), 2.03 (3H, s), 1.82 (2H, quintet, J 7.3 Hz), 1.56–
1.49 (1H, m), 1.44 (3H, br pent., J 7.6 Hz), 1.38–1.09 (66H, br m),
0.89 (3H, t, J 7.0 Hz); dC: 173.6, 170.4, 156.3, 130.0, 129.7 (v. br.),
123.8, 74.1, 51.5, 49.6, 33.3, 31.9, 31.7, 29.7, 29.6, 29.5, 29.4, 29.04,
29.0, 28.6, 28.1, 27.4, 25.0, 22.7, 21.0, 14.1; nmax: 2922, 2853, 1743,
cosanoic acid methyl ester 53 (R¼SiMe2But) (790 mg, 91%), ½a 2D3
ꢂ
ꢀ6.8 (c 0.31, CHCl3), {Found (MþNa)þ: 1432.3752, C93H184NaO5Si
requires: 1432.3805}. This showed dH: 5.10 (1H, dt, J 3.8, 7.9 Hz),
3.69 (3H, s), 3.52–3.49 (1H, m), 2.63 (1H, ddd, J 4.2, 6.8, 10.7 Hz),
2.04 (3H, s), 1.68–1.14 (146H, m, v. br.), 1.07–1.02 (1H, m), 0.91–
0.88 (15H, m, including a s), 0.80 (3H, d, J 6.6 Hz), 0.69–0.65
(2H, m), 0.57 (1H, br.dt, J 4.1, 8.2 Hz), 0.04 (3H, s), 0.03 (3H,
s), ꢀ0.32 (1H, br.q, J 5.4 Hz); dC: 173.6, 170.3, 75.9, 74.1, 51.5, 49.6,
37.7, 33.6, 32.5, 31.9, 31.7, 30.2, 30.0, 29.9, 29.7(v. br.), 29.7, 29.6,
29.5, 29.4, 29.4, 29.4, 28.7, 28.1, 27.7, 27.5, 26.0, 25.9, 25.0, 22.7,
21.0, 18.2, 15.8, 14.4, 14.1, 10.9, ꢀ4.2, ꢀ.4; nmax: 2924, 2853, 1747,
1598, 1501, 1466, 1385, 1238, 1166, 1074, 1017 cmꢀ1
.
3.1.36. (R)-2-[(R)-1-Acetoxy-15-(5-phenyl-5H-tetrazol-1-
sulfonyl)pentadecyl]hexacosanoic acid methyl ester 52. m-
Chloroperbenzoic acid (1.85 g, 5.43 mmol) in dichloromethane
(40 ml) was added at 0 ꢁC to (R)-2-[(R)-1-acetoxy-15-(5-phe-
1465, 1372, 1236 cmꢀ1
.
nyl-5H-tetrazol-1-ylsulfanyl)pentadecyl]hexacosanoic
acid
methyl ester (2.28 g, 2.68 mmol) and NaHCO3 (1.02 g,
12.20 mmol) in dichloromethane (40 ml) and stirred at rt for
20 h. The mixture was quenched by addition of a satd aq
NaHCO3 (50 ml) and extracted with dichloromethane
(1ꢃ100 ml, 3ꢃ30 ml). The combined organic phases were
washed with water (100 ml), dried and the solvent evaporated.
Chromatography eluting with petrol/ether (5:1) gave a white
solid, (R)-2-[(R)-1-acetoxy-15-(5-phenyl-5H-tetrazol-1-sulfo-
nyl)pentadecyl]hexacosanoic acid methyl ester 52 (1.94 g, 82%),
3.1.38. (R)-2-((R)-1-Acetoxy-16-{(1S,2R)-2-[(19S,20S)-19-(tert-bu-
tyldimethylsilanyloxy)-20-methyloctatriacontyl]cyclopropyl}-
octadecyl)hexacosanoic acid methyl ester 55 (R¼SiMe2But). Ester 52
(0.93 g, 1.04 mmol) was dissolved in dry THF (15 ml) and a solution
of (1S,2R)-2-[(19S,20S)-19-(tert-butyldimethylsilanyloxy)-20-met-
hyloctatriacontyl]cyclopropanecarbaldehyde (0.78 g, 1.04 mmol) in
dry THF (10 ml) was added at rt. This solution was cooled to ꢀ12 ꢁC
and lithium bis(trimethylsilyl) amide (1.5 ml, 1.59 mmol, 1.06 M)
was added, then allowed to reach rt and stirred for 2 h. Ether
(25 ml) and satd aq ammonium chloride (30 ml) were added. The
organic phase was separated and water layer was extracted with
petrol/ether (20:1, 3ꢃ100 ml). The combined organic layers were
dried and the solvent was evaporated. Chromatography eluting
with petrol/ether (20:1) gave a colourless oil, (R)-2-((R)-1-acetoxy-
16-{(1S,2R)-2-[(19S,20S)-19-(tert-butyldimethylsilanyloxy)-20-
methyloctatriacontyl]cyclopropyl}hexadec-15-enyl)hexacosanoic
acid methyl ester (1.29 g, 88%) as a 4:1 mixture of two isomers.
Dipotassium azo-dicarboxylate (3.0 g, 15.46 mmol) was added to
½
a 1D8
ꢂ
þ10.6 (c 0.83, CHCl3) {Found (MþNa)þ: 909.6448,
C51H90N4O6SNa requires: 909.6473}. This showed dH: 7.71–7.67
(2H, m), 7.65–7.56 (3H, m), 5.08 (1H, ddd, J 4.1, 6.9, 10.7 Hz), 3.73
(2H, distorted t, J 8.2 Hz), 3.68 (3H, s), 2.62 (1H, ddd, J 4.4, 7.0,
11.1 Hz), 2.03 (3H, s), 1.95 (2H, br quintet, J 7.9 Hz), 1.69–1.56
(3H, m), 1.55–1.41 (4H, m), 1.39–1.09 (63H, br m), 0.88 (3H, t, J
6.6 Hz); dC: 173.6, 170.3, 153.5, 133.1, 131.4, 129.7, 125.1, 74.1,
56.0, 51.5, 49.6, 31.9, 31.7, 29.7 (v. br.), 29.6, 29.5, 29.4, 29.3, 29.1,
28.9, 28.1, 27.4, 24.9, 22.6, 21.9, 21.0, 14.1; nmax: 3439, 2972,

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10225
a stirred solution of the mixture (1.06 g, 0.81 mmol) in THF (20 ml)
and methanol (5 ml) at 5 ꢁC. Half of a solution of glacial acetic acid
(5 ml) and THF (2 ml) was added dropwise at 5 ꢁC and the mixture
was stirred at rt for 2 h. The other half was added and the mixture
was stirred overnight. Dipotassium azo-dicarboxylate (2.50 g) and
then glacial acetic acid (2 ml) were added and stirred again over-
night. This mixture was slowly added to satd aq ammonium
chloride and extracted with petrol/ether (1:1, 3ꢃ80 ml,) and the
combined organic layers were washed with water (50 ml) and the
solvent was evaporated. The procedure was repeated. Chroma-
tography eluting with petrol/ether (20:1) gave a white semi-solid,
methanol (0.5 ml) and water (0.5 ml) at rt After 18 h at 45 ꢁC, it was
cooled to rt and petrol and ether (1:1, 10 ml) were added and the
mixture acidified to pH 1 by addition of 5% HCl. Further petrol/ether
(1:1, 10 ml) was added and extracted. The aq layer was re-extracted
with petrol/ether (1:1, 2ꢃ10 ml). The combined organic layers were
washed with water (5 ml), dried and evaporated. Chromatography
eluting with petrol/ethyl acetate (3:1) gave a white solid, (R)-2-
{(R)-1-hydroxy-16-[(1R,2S)-2-((19S,20S)-19-hydroxy-20-methylocta
triacontyl)cyclopropyl]hexadecyl}hexacosanoic acid 54þ(57 mg, 85%),
½
a 2D0
ꢂ
–0.5 (c 0.97, CHCl3), mp 73–74 ꢁC {Found (MþNa) : 1262.2618,
C84H166NaO4 requires: 1262.2678}. This showed dH: 3.74–3.70 (1H, m),
3.53–3.50 (1H, m), 2.46 (1H, dt, J 8.8, 5.4 Hz), 1.77–1.60 (1H, m),
1.67–1.12 (149H, m), 0.89 (6H, t, J 7.0 Hz), 0.87 (3H, d, J 7.0 Hz), 0.68–
0.64 (2H, m), 0.57 (1H, br.dt, J 4.1, 8.2 Hz), - 0.32 (1H, br.q, J 5.4 Hz);
dC: 178.4, 75.4, 72.1, 50.7, 38.1, 35.6, 34.4, 33.3, 31.9, 30.2, 29.9, 29.7(v.
br.), 29.65, 29.61, 29.59, 29.55, 29.51, 29.43, 29.36, 28.7, 27.4, 27.3,
26.3, 25.7, 22.7, 15.8, 14.1, 13.6, 10.9; nmax: 3333, 2917, 2851, 1719,
(R)-2-((R)-1-acetoxy-16-{(1S,2R)-2-[(19S,
20S)-19-(tert-butyldi-
methylsilanyloxy)-20-methyloctatriacontyl]cyclopropyl}octadecyl)-
hexacosanoic acid methyl ester 55 (R¼SiMe2But) (960 mg, 84%),
½
a D
ꢂ
23 –3.6 (c0.58, CHCl3){Found(MþNa)þ:1432.3763, C93H184NaO5Si
requires: 1432.3805}, which showed essentially identical NMR
and IR spectra to those of 53 (R¼SiMe2But) above.
1519 cmꢀ1
.
3.1.39. (R)-2-((R)-1-Acetoxy-16-{(1R,2S)-2-[(19S,20S)-19-hydroxy-
20-methyloctatriacontyl]cyclopropyl}octadecyl)hexacosanoic
acid
3.1.42. (R)-2-{(R)-1-Hydroxy-16-[(1S,2R)-2-((19S,20S)-19-hydroxy-
20-methyloctatriacontyl)cyclopropyl]-hexadecyl}hexacosanoic acid
56. Lithium hydroxide monohydrate (67 mg, 1.60 mmol) was
added at rt with stirring to ester 55 (R¼H) (70 mg, 0.05 mmol) in
THF (5 ml), methanol (0.5 ml) and water (0.5 ml). The mixture
was stirred at 45 ꢁC for 18 h, then cooled to rt and petrol/ether
(1:1, 10 ml) was added and the mixture was acidified to pH 1 by
addition of 5% HCl. Further petrol/ether (1:1, 10 ml) was added
and extracted. The aq layer was re-extracted with petrol/ether
(1:1, 2ꢃ10 ml). The combined organic layers were washed with
water (5 ml), dried and evaporated. Chromatography eluting with
3:1 petrol/ethyl acetate gave a white solid, (R)-2-{(R)-1-hydroxy-16-
[(1S,2R)-2-((19S,20S)-19-hydroxy-20-methyloctatriacontyl)cyclopro-
methyl ester 53 (R¼H). Ester 53 (R¼SiMe2But) (880 mg, 0.62 mmol)
was dissolved in dry THF (12 ml) in a dry polyethylene vial under
argon at rt and stirred. Pyridine (0.5 ml) and HF.pyridine (1.0 ml)
were added and the mixture was stirred for 17 h at 40 ꢁC, then
diluted with petrol/ether (1:1, 70 ml,) and neutralized with satd aq
NaHCO3. The mixture was extracted and the aqueous layer was
re-extracted with petrol/ether (1:1, 2ꢃꢃ50 ml). The combined
organic layers were washed with brine, dried and evaporated.
Chromatography eluting with petrol/ether (5:2) gave a white semi-
solid, (R)-2-((R)-1-acetoxy-16-{(1R,2S)-2-[(19S,20S)-19-hydroxy-20-
methyloctatriacontyl]cyclopropyl}octadecyl)hexacosanoic acid
methyl ester 53 (R¼H) (580 mg, 73%), ½a D19
ꢀ1.9 (c 0.91, CHCl3), mp
ꢂ
40–42 ꢁC {Found (MþNa)þ: 1318.2785, C87H170NaO4 requires:
1318.2940}. This showed dH: 5.08 (1H, br.dt, J 3.8, 7.9 Hz), 3.69 (3H,
s), 3.51–3.48 (1H, m), 2.62 (1H, ddd, J 4.3, 6.8, 10.7 Hz), 2.04 (3H,
s), 1.66–1.12 (151H, m, v. br.), 0.90 (3H, t, J 6.9 Hz), 0.86 (3H, d, J
7.0 Hz), 0.67–0.64 (2H, m), 0.57 (1H, br. dt, J 4.1, 8.2 Hz), - 0.32
(1H, br. q, J 5.4 Hz); dC: 173.7, 170.3, 75.2, 74.1, 51.5, 49.6, 38.2,
34.5, 33.4, 31.9, 31.7, 30.2, 27.0, 29.8, 29.7(v. br.), 29.66, 29.57,
29.47, 29.44, 29.40, 29.36, 28.7, 28.1, 27.5, 27.4, 26.3, 25.0, 22.7,
21.0, 15.8, 14.1, 13.6, 10.9; nmax: 3427, 2918, 2849, 1745, 1469, 1373,
pyl]hexadecyl}hexacosanoic acid 56 (60 mg, 86%), ½a D22
þ0.05 (c
ꢂ
0.86, CHCl3), mp 58–60 ꢁC, {Found (MþNa)þ: 1262.2752C84H166
NaO4 requires: 1262.2678}, which showed an essentially identical
NMR spectrum to that above.
3.1.43. 2,2-Dimethyl-propionic acid 10-{(1R,2S)-2-[(19R,20R)-19-
(tert-butyldimethylsilanyloxy)-20-methyloctatriacontyl]cyclopro-
pyl}decyl ester 58. 2,2-Dimethylpropionic acid 9-(2-phenyl-2H-
pentazol-1-sulfonyl)nonyl ester (57) (prepared as for 12; see
Supplementary data) (0.95 g, 2.18 mmol) was dissolved in dry THF
(20 ml) and a solution of (1R,2S)-aldehyde 22 (1.3 g, 1.74 mmol) in
dry THF (20 ml) was added at rt. This solution was cooled to ꢀ12 ꢁC
and lithium bis(trimethylsilyl) amide (2.96 ml, 3.14 mmol, 1.06 M)
was added at between ꢀ12 and ꢀ4 ꢁC. The solution was allowed to
reach rt and stirred for 2 h. Petrol/ether (1:1, 50 ml) and satd aq
ammonium chloride (100 ml) were added. The organic phase was
separated and the water layer was extracted with petrol/ether (1:1,
2ꢃ40 ml). The combined organic layers were dried and the solvent
was evaporated. Chromatography eluting with petrol/ether (33:1)
gave a colourless oil, 2,2-dimethyl-propionic acid (E/Z)-10-{(1R,2S)-
2-[(19R, 20R)-19-(tert-butyldimethylsilanyloxy)-20-methylocta-
tria-contyl]cyclopropyl}-dec-9-enyl ester (1.45 g, 87%) as a mixture
of two isomers in ratio 5.9:1 {Found (MþNa)þ: 979.9184,
C63H124NaO3Si requires: 979.9212}. The alkene (1.4 g, 1.46 mmol)
and 2,4,6-triisopropylbenzenesulfonylhydrazine (1.53 g, 5.13 mmol)
were stirred in dry THF (40 ml) at 45 ꢁC for 24 h. Further TPBSH
(0.52 g, 1.75 mmol) was added and stirred at 45 ꢁC for another 24 h.
The mixture was diluted with petrol/ether (1:2, 100 ml) and aq
sodium hydroxide (30 ml, 2%) was added and extracted. The
aqueous layer was re-extracted with petrol/ether (1:2, 2ꢃ25 ml)
and the combined organic layers were washed with water (100 ml),
dried and evaporated. Chromatography eluting with petrol/ether
1237 cmꢀ1
.
3.1.40. (R)-2-((R)-1-Acetoxy-16-{(1S,2R)-2-[(19S,20S)-19-hydroxy-
20-methyloctatriacontyl]cyclopropyl}octadecyl)hexacosanoic acid
methyl ester 55 (R¼H). Ester 55 (R¼SiMe2But) (880 mg,
0.62 mmol) was stirred in dry THF (15 ml) in a dry polyethylene
vial under argon at rt. Pyridine (0.5 ml) and HF.pyridine (1.0 ml)
were added and the mixture was stirred for 17 h at 40 ꢁC. The
reaction was diluted with petrol/ether (1:1, 70 ml) and neutral-
ized with satd aq NaHCO3. The mixture was separated and the
aqueous layer was re-extracted with petrol/ether (1:1, 2ꢃ50 ml).
The combined organic layers were washed with brine, dried and
the solvent was evaporated. Chromatography eluting with
petrol/ether (5:1) gave a white solid, (R)-2-((R)-1-acetoxy-16-
{(1S,2R)-2-[(19S,20S)-19-hydroxy-20-methyloctatriacontyl]cyclo-
propyl}octadecyl)hexacosanoic acid methyl ester 55 (R¼H)
(780 mg, 96%), ½a D23
ꢂ
ꢀ2.8 (c 0.88, CHCl3), mp 47–49 ꢁC {Found
(MþNa)þ: 1318.2886, C87H170NaO5 requires: 1318.2940}. This
showed an essentially identical NMR spectrum to that for 53
(R¼H) above.
3.1.41. (R)-2-{(R)-1-Hydroxy-16-[(1R,2S)-2-((19S,20S)-19-hydroxy-
20-methyloctatriacontyl)cyclopropyl]hexadecyl}hexacosanoic
acid
54. Lithium hydroxide monohydrate (68 mg, 1.62 mmol) was added
to ester 53 (R¼H) (70 mg, 0.054 mmol) stirred in THF (5 ml),
(33:1) gave
a colourless oil, 2,2-dimethylpropionic acid 10-
{(1R,2S)-2-[(19R,20R)-19-(tert-butyldimethylsilanyloxy)-20-

10226
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
methyloctatriacontyl]cyclopropyl}decyl ester 58 (1.3 g, 93%), ½a D19
ꢂ
dimethylsilanyloxy)-20-methyloctatriacontyl]cyclo-propyl}hexadec-
6-enyl)hexacosanoic acid methyl ester (0.45 g, 56%) as a 2:1 mixture
of isomers, {Found (MþNa)þ: 1430.3699, C93H182NaO5Si requires:
1430.3649}. Dipotassium azodicarboxylate (2 g, 10.3 mmol) was
added with stirring to the above alkenes (400 mg, 0.28 mmol) in THF
(20 ml) and methanol (4 ml) at 5 ꢁC. A solution of glacial acetic acid
(2.5 ml) and THF (2.5 ml) was prepared and half of this solution was
added at 5 ꢁC dropwise and the mixture was stirred at rt for 2 h. The
other half of the glacial acetic acid solution was added at rt and the
mixture was stirred overnight. Dipotassium azodicarboxylate (1.5 g)
was added and glacial acetic acid (2 ml) was added and stirred again
overnight. This mixture was added slowly to satd aq ammonium
chloride and extracted with petrol/ether (1:1, 3ꢃ80 ml) and the
combined organic layers were washed with water (50 ml) and
evaporated. The procedure was repeated. Chromatography eluting
with petrol/ether (15:1) gave a white solid, (R)-2-((R)-1-acetoxy-16-
{(1R,2S)-2-[(19R,20R)-19-(tert-butyldimethylsilanyloxy)-20-meth-
yloctatriacontyl]cyclopropyl}hexadecyl)hexacosanoic acid methyl
þ5.6 (c 1.3, CHCl3) {Found (MþNa)þ: 981.9332, C63H126NaO3Si re-
quires: 981.9368}. This showed dH: 4.05 (2H, t, J 6.6 Hz), 3.51 (1H, dt,
J 3.5, 6.3 Hz), 1.66–1.60 (2H, m), 1.50–1.12 (86H, m, v. br.), 1.21 (9H,
s), 1.10–1.02 (1H, m), 0.91–0.88 (12H, s and t, J 6.7 Hz), 0.81 (3H, d, J
6.6 Hz), 0.67–0.63 (2H, m), 0.58 (1H, br.dt, J 4.1, 8.2 Hz), 0.04 (3H, s),
0.03 (3H, s), ꢀ0.32 (1H, br.q, J 5.1 Hz); dC: 178.6, 75.9, 64.5, 38.7, 37.7,
33.6, 32.5, 31.9, 30.2, 30.0, 29.9, 29.75, 29.7(v. br.), 29.57, 29.52, 29.4,
29.3, 28.7, 28.6, 27.7, 27.2, 26.0, 25.9, 22.7, 18.2, 15.8, 14.4, 14.1, 10.9,
ꢀ4.2, ꢀ4.4; nmax: 2925, 2854, 1733, 1464, 1284, 1253, 1155 cmꢀ1
.
3.1.44. 10-{(1R,2S)-2-[(19R,20R)-19-(tert-Butyldimethylsilanyloxy)-
20-methyloctatriacontyl]cyclopropyl}decanal 59.
(i) The ester 58 (1.2 g, 1.25 mmol) in dry THF (10 ml) was added
dropwise over 15 min to a suspension of lithium aluminium
hydride (71 mg,1.88 mmol,1.5 mol equiv) inTHF (20 ml) at 0 ꢁC
under nitrogen, then refluxed for 1 h. Satd aq sodium sulfate
decahydrate was added at 0 ꢁC until a white precipitate had
formed. THF (25 ml) was added and the mixturewas stirred at rt
for 30 min, filtered through silica and the solvent was evapo-
rated. Chromatography eluting with petrol/ether (2:1) gave
a colourless oil, 10-{(1R,2S)-2-[(19R,20R)-19-(tert-butyldime-
thylsilanyloxy)-20-methyloctatriacontyl]cyclopropyl}decan-1-
ester 60 (350 mg, 88%), mp 29–30 ꢁC, ½a D24
þ7.9 (c 0.79, CHCl3)
ꢂ
{Found (MþNa)þ: 1432.3752, C93H184NaO5Si requires: 1432.3805};
nmax: 2924, 2853, 1747, 1465, 1372, 1236, 1164, 1022 cmꢀ1. This
showed an essentially identical NMR spectra to 53 (R¼SiMe2But)
and 55 (R¼SiMe2But) above.
ol (0.75 g, 69%), ½a D25
ꢂ
þ5.9 (c 1.16, CHCl3) {Found (M–H)þ:
3.1.46. (R)-2-{(R)-1-Acetoxy-16-[(1R,2S)-2-((19R,20R)-19-hydroxy-
873.8788, C58H117O2Si requires: 873.8817}. This showed dH
:
20-methyloctatriacontyl)cyclopropyl]hexadecyl}hexacosanoic
acid
3.65 (2H, t, J 6.6 Hz), 3.51 (1H, dt, J 3.5, 6.3 Hz),1.60–1.55 (2H, m),
1.51–1.14 (86H, m, v. br.), 1.09–1.02 (1H, m), 0.91–0.88 (12H, s
and t, J 6.9 Hz), 0.80 (3H, d, J 6.7 Hz), 0.68–0.63 (2H, m), 0.57 (1H,
br.dt, J 4.1, 8.2 Hz), 0.04 (3H, s), 0.03 (3H, s), ꢀ0.32 (1H, br.q, J
5.4 Hz); dC: 75.9, 63.1, 37.7, 33.6, 32.8, 32.5, 31.9, 30.2, 30.0, 29.9,
29.7(v. br.), 29.62, 29.6, 29.5, 29.4, 28.7, 27.7, 26.0, 25.9, 25.8,
22.7,18.2,15.8,14.4,14.1,10.9, ꢀ.2, ꢀ4.4; nmax: 3332, 2924, 2854,
methyl ester 61. The methyl ester 60 (300 mg, 0.21 mmol) was dis-
solved in dry THF (15 ml) in a dry polyethylene vial under argon at rt
and stirred. Pyridine (0.3 ml) and HF.pyridine (1.2 ml) were added
and the mixture was stirred for 17 h at 40 ꢁC. The reaction was diluted
with petrol/ether (1:1, 70 ml) and neutralized with satd aq NaHCO3,
then separated and the aqueous layer was re-extracted with petrol/
ether (1:1, 2ꢃ50 ml). The combined organic layers were washed with
brine, dried and evaporated. Chromatography eluting with petrol/
ether (4:1) gave a white solid, (R)-2-{(R)-1-acetoxy-16-[(1R,2S)-
2-((19R,20R)-19-hydroxy-20-methyloctatriacontyl)cyclopropyl]hex-
adecyl}hexacosanoic acid methyl ester 61 (260 mg, 94%), mp
1465, 1253, 1058 cmꢀ1
.
(ii) A solution of the above alcohol (0.62 g, 0.73 mmol) in
dichloromethane (20 ml) was added with stirring to PCC
(0.38 g,1.77 mmol) in dichloromethane (60 ml) at rt. After 2 h it
was diluted with ether (50 ml), filtered through a bed of silica
and the solvent was evaporated. Chromatography eluting
with petrol/ether (15:1) gave a colourless oil, 10-{(1R,2S)-2-
[(19R,20R)-19-(tert-butyldimethylsilanyloxy)-20-methylocta-
47–48 ꢁC, ½a 2D1
ꢂ
þ9.3 (c 0.95, CHCl3) {Found (MþNa)þ: 1318.3003,
C87H170NaO5 requires: 1318.2940}; nmax: 3449, 2918, 2850,1743,1470,
1374, 1238 cmꢀ1. This showed essentially identical NMR spectra to 53
(R¼H) and 55 (R¼H) above.
triacontyl]cyclopropyl}decanal 59 (0.59 g, 95%), ½a D24
þ5.1 (c
ꢂ
0.9, CHCl3) {Found (MþNa)þ: 895.8638, C58H116NaO2Si re-
quires: 895.8637}. This showed dH: 9.77 (1H, t, J 1.9 Hz), 3.52–
3.48 (1H, m), 2.43 (2H, dt, J 1.9, 7.4 Hz), 1.64 (2H, quintet, J
7.3 Hz), 1.51–1.14 (84H, m, v. br.), 1.09–1.01 (1H, m), 0.90–0.87
(12H, m, including a s), 0.80 (3H, d, J 6.7 Hz), 0.67–0.64 (2H, m),
0.57 (1H, br.dt, J 4.1, 8.2 Hz), 0.04 (3H, s), 0.03 (3H, s), ꢀ0.32 (1H,
br.q, J 5.4 Hz); dC: 202.9, 75.9, 43.9, 37.7, 33.6, 32.5, 31.9, 30.2,
30.2, 30.0, 29.9, 29.7(v. br.), 29.64, 29.62, 29.44, 29.36, 29.2, 28.7,
28.7, 27.7, 26.0, 25.9, 22.7, 22.1, 18.2, 15.8, 15.8, 14.4, 14.1, 10.9,
3.1.47. (R)-2-{(R)-1-Hydroxy-16-[(1R,2S)-2-((19R,20R)-19-hydroxy-
20-methyloctatriacontyl)cyclopropyl]hexadecyl}hexacosanoic
acid
62. Lithium hydroxide monohydrate (23 mg, 0.55 mmol) was added
to ester 61 (24 mg, 0.019 mmol) stirred in THF (5 ml), methanol
(0.5 ml) and water (0.4 ml) at rt, then heated to 45 ꢁC for 18 h. After
cooling to rt, petrol/ether (1:1, 10 ml) and then sat aq ammonium
chloride (5 ml) were added and the mixture was acidified to pH 1 by
addition of 5% HCl. Further petrol/ether (1:1, 10 ml) was added and
extracted. The aq layer was re-extracted with petrol/ether (1:1,
2ꢃ10 ml). The combined organic layers were washed with water
(5 ml), dried and the solvent evaporated. Chromatography eluting
with petrol/ethyl acetate (3:1) gave a white solid, (R)-2-{(R)-1-hy-
droxy-16-[(1R,2S)-2-((19R,20R)-19-hydroxy-20-methyloctatri-
acontyl)cyclopropyl]hexadecyl}hexacosanoic acid 62 (14 mg, 61%),
ꢀ4.2, ꢀ4.4; nmax: 2932, 2854, 1731, 1465, 1361, 1253, 1074 cmꢀ1
.
3.1.45. (R)-2-((R)-1-Acetoxy-16-{(1R,2S)-2-[(19R,20R)-19-(tert-bu-
tyldimethylsilanyloxy)-20-methyloctatriacontyl]cyclopropyl}-
hexadecyl)hexacosanoic acid methyl ester 60. Ester 39 (0.54 g,
0.72 mmol) was dissolved in dry THF (30 ml) and a solution of
(1R,2S)-aldehyde 59 (0.5 g, 0.57 mmol) in dry THF (10 ml) was added
at rt After cooling to ꢀ12 ꢁC lithium bis-(trimethylsilyl)amide
(1.05 ml, 1.09 mmol, 1.06 M) was added. After stirring at rt for 2 h.
Ether (25 ml) and satd aq ammonium chloride (30 ml) were added.
The aqueous layer was extracted with petrol/ether (1:2, 2ꢃ40 ml).
The combined organic layers were dried and evaporated. Chroma-
tography eluting with petrol/ether (18:1) gave a colourless oil,
(R)-2-((E/Z)-(R)-1-acetoxy-16-{(1R,2S)-2-[(19R,20R)-19-(tert-butyl-
mp 64–66 ꢁC, ½a 2D5
ꢂ
þ9.1 (c 0.6, CHCl3) {Found (MþNa)þ: 1262.16,
C84H166NaO4 requires: 1262.27; Found: C, 81.4; H, 13.3, C84H166O4
requires: C, 81.35; H,13.49}; nmax: 3331, 2921, 2852,1688,1463,1377,
1201 cmꢀ1. This showed essentially identical NMR spectra to 54 and
56 above.
3.1.48. (R)-2-{(R)-1-Acetoxy-16-[(1R,2S)-2-((R)-20-methyl-19-oxo-
octatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid methyl ester
65. Ester 61 (150 mg, 0.12 mmol) in dichloromethane (5 ml)
was added in portions to PCC (62.5 mg, 0.29 mmol) stirred in

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10227
3.70 (1H, m), 2.51 (1H, sext, J 6.9 Hz), 2.46 (1H, dt, J 8.8, 5.4 Hz),
2.43 (1H, dt, J 14.8, 7.3 Hz), 2.40 (1H, dt, J 14.8, 7.3 Hz), 1.75–1.12
(144H, m, v. br.),1.05 (3H, d, J 7.0 Hz), 0.89 (6H, t, J 7.0 Hz), 0.69–
0.64 (2H, m), 0.57 (1H, br.dt, J 4.1, 8.2 Hz), - 0.32 (1H, br.q, J
5.4 Hz); dC: 215.4, 179.6, 72.1, 50.8, 46.3, 41.1, 35.5, 33.0, 31.9,
30.2, 29.7(v. br.), 29.66, 29.60, 29.52, 29.50, 29.46, 29.43, 29.36,
29.33, 28.7, 27.3, 25.7, 23.7, 22.7,16.4,15.8,14.1,10.9; nmax: 3285,
dichloromethane (25 ml) at rt After 3 h, it was diluted with ether
(40 ml), filtered through silica and the solvent evaporated.
Chromatography eluting with petrol/ether (6:1) gave a white solid,
(R)-2-{(R)-1-acetoxy-16-[(1R,2S)-2-((R)-20-methyl-19-oxo-octa-
triacontyl)cyclopropyl]hexadecyl}hexacosanoic acid methyl ester
65 (150 mg, 100%), mp 49–50 ꢁC, ½a D20
þ3.0 (c 0.7, CHCl3) {Found
ꢂ
(MþNa)þ: 1316.2779, C87H168NaO5 requires: 1316.2784}. This
showed dH: 5.09 (1H, dt, J 3.8, 7.9 Hz), 3.69 (3H, s), 2.62 (1H, ddd, J
4.4, 6.9, 10.7 Hz), 2.50 (1H, sext, J 6.8 Hz), 2.43 (1H, dt, J 14.7,
7.3 Hz), 2.40 (1H, dt, J 14.7, 7.3 Hz), 2.03 (3H, s), 1.68–1.14 (144H,
m, v. br.), 1.05 (3H, d, J 7.0 Hz), 0.89 (6H, t, J 7.0 Hz), 0.68–0.64
2919, 2850, 1707, 1470, 1377, 1204, 1019 cmꢀ1
.
(ii) Lithium hydroxide monohydrate (64.26 mg, 1.53 mmol) was
added to ester 63 (66 mg, 0.051 mmol) stirred in THF (5 ml),
methanol (0.5 ml) and water (0.5 ml) at rt. The mixture was
stirred at 45 ꢁC for 18 h, cooled to rt and petrol/ether (1:1,
10 ml) was added and acidified to pH 1 by adding 5% HCl.
Further petrol/ethyl acetate (5:2, 20 ml) was added and
extracted. The aq layer was re-extracted with petrol/ethyl
acetate (5:2, 4ꢃ20 ml). The combined organic layers were
washed with water (15 ml), dried and evaporated. Chroma-
tography eluting with petrol/ethyl acetate (7:2) gave a white
(2H, m), 0.57 (1H, br.dt, J 4.1, 8.2 Hz), - 0.32 (1H, br.q, J 5.0 Hz); dC
:
215.1, 173.6, 170.3, 74.1, 51.5, 49.6, 46.3, 41.1, 33.1, 31.9, 31.7, 30.2,
29.8, 29.7(v. br.), 29.65, 29.63, 29.60, 29.56, 29.51, 29.49, 29.46,
29.44, 29.40, 29.36, 28.7, 28.1, 27.5, 27.3, 25.0, 23.7, 22.7, 21.0, 16.4,
15.8, 14.1, 10.9; nmax: 2919, 2850, 1740, 1708, 1471, 1376, 1241, 1166,
1020 cmꢀ1
.
solid, the acid 66 (55 mg, 87%), ½a D20
þ4.9 (c 0.70, CHCl3), mp
ꢂ
3.1.49. (R)-2-{(R)-1-Acetoxy-16-[(1R,2S)-2-((S)-20-methyl-19-
oxooctatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid methyl
ester 63. The ester 53 (150 mg, 0.116 mmol) in dichloromethane
(5 ml) was added in portions to a stirred solution of PCC (74.8 mg,
0.347 mmol) in dichloromethane (10 ml) at rt. The mixture was stirred
for 3 h then diluted with ether (10 ml), filtered through silica and
evaporated. Chromatography eluting with petrol/ether (5:1) gave
a white solid, (R)-2-{(R)-1-acetoxy-16-[(1R,2S)-2-((S)-20-methyl-19-
oxo-octatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid methyl
71–73 ꢁC {Found (MþNa)þ: 1260.2501, C84H164NaO4 requires:
1260.2522}, which showed an identical NMR spectrum to that
above.
3.1.52. (R)-2-{(R)-1-Hydroxy-16-[(1S,2R)-2-((R/S)-20-methyl-19-
oxo-octatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid 67.
Lithium hydroxide monohydrate (48.7 mg,1.16 mmol) was added to
ester 64 (50 mg, 0.039 mmol) stirred in THF (5 ml), methanol
(0.5 ml) and water (0.5 ml) at rt. After 18 h at 45 ꢁC, it was cooled to
rt, petrol/ethyl acetate (5:2,10 ml) was added and it was acidified to
pH 1 byaddition of 5% HCl. Theaq layer was re-extractedwith petrol/
ethyl acetate (5:2, 5ꢃ20 ml). The combined organic layers were
washed with water (15 ml), dried and evaporated. Chromatography
elutingwithpetrol/ethylacetate(7:2)gaveawhitesolid, (R)-2-{(R)-1-
hydroxy-16-[(1S,2R)-2-((R/S)-20-methyl-19-oxo-octatriacontyl)cyc-
ester 63 (134 mg, 89%), mp 49–50 ꢁC ½a D20
þ7.3 (c 0.86, CHCl3) {Found
ꢂ
(MþNa)þ: 1316.2784, C87H168NaO5 requires: 1316.2784}, which
showed an essentially identical NMR spectrum to that of its
diastereoisomer 65 above.
3.1.50. (R)-2-{(R)-1-Acetoxy-16-[(1S,2R)-2-((S)-20-methyl-19-oxo-
octatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid methyl ester
64. Ester 55 (150 mg, 0.116 mmol) was dissolved in dichloromethane
(5 ml) and added in portions to a stirred solution of PCC (74.8 mg,
0.347 mmol) in dichloromethane (10 ml) at rt. The mixture was
stirred for 3 h then diluted with ether (40 ml) and filtered through
silica. The solvent was evaporated. Chromatography eluting with
petrol/ether (6:1) gave a white solid, (R)-2-{(R)-1-acetoxy-16-
[(1S,2R)-2-((S)-20-methyl-19-oxo-octatriacontyl)cyclopropyl]hexa-
decyl}hexacosanoic acid methyl ester 64 (135 mg, 90%), mp
lopropyl]hexadecyl}hexacosanoic acid 67 (41 mg, 87%), ½a D23
ꢂ þ3.5
(c 0.59, CHCl3), mpmp 73–75 ꢁC {Found (MþNa)þ: 1260.2478,
C84H164NaO4 requires: 1260.2522}. This showed an essentially iden-
tical NMR to that of 66 above.
3.1.53. ((R)-2-((R)-1-acetoxy-16-{(1R,2S)-2-[(19S,20S)-20-methyl-19-
(tetrahydropyran-2-yloxy)octatriacontyl]cyclopropyl}hexade-
cyl)hexacosanoic acid methyl ester 68. Pyridinium p-toluene sulfonate
(24 mg, 0.095 mmol) in dry dichloromethane (0.5 ml) was added with
stirring to ester 53 (R¼H) (254 mg, 0.196 mmol) and freshly distilled
dihydro-2H-pyran (0.2 ml, 2.206 mmol) in dry dichloromethane
(5 ml) at rt under nitrogen. After 1.5 h, the reaction was quenched
with a satd aq NaHCO3 (10 ml), extracted with dichloromethane
(3ꢃ30 ml) and the combined organic layers were dried and evapo-
rated. Chromatography, eluting with petrol/ether (5:2) with a few
drops of Et3N gave a white semi-solid, ((R)-2-((R)-1-acetoxy-16-
{(1R,2S)-2-[(19S,20S)-20-methyl-19-(tetrahydropyran-2-yloxy)oc-
tatriacontyl]cyclopropyl}hexadecyl)hexacosanoic acid methyl
ester as a mixture of diastereoisomers 68 (230 mg, 86%). {Found
(MþNa)þ: 1402.3516, C92H178NaO6 requires: 1402.3466}. This showed
dH: 5.09 (2H, ddd, J 3.8, 7.9,10.8 Hz), 4.66 (1H, br., t, J 3.15 Hz), 4.62 (1H,
br., t, J 2.5 Hz), 3.95–3.69 (2H, m), 3.69 (6H, s), 3.51–3.43 (4H, m), 2.62
(2H, ddd, J 4.4, 7.0, 10.7 Hz), 2.04 (6H, s), 1.85–1.80 (2H, m), 1.73–1.05
(304H, m), 0.88 (12H, t, J 7.25 Hz), 0.85 (6H, d, J 6.9 Hz), 0.68–0.62 (4H,
m), 0.57 (2H, br., dt, J 4.1, 8.2 Hz), ꢀ0.33 (2H, br., q, J 5.1 Hz); nmax: 2849,
59–60 ꢁC, ½a 2D0
ꢂ
þ8.1 (c 0.94, CHCl3) {Found (MþNa)þ: 1316.2780,
C87H168NaO5 requires: 1316.2784}. Thisshowed an essentially identical
NMR spectrum to that of its diastereoisomers 65 and 63 above.
3.1.51. (R)-2-{(R)-1-Hydroxy-16-[(1R,2S)-2-((R/S)-20-methyl-19-
oxo-octatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid 66.
(i) Lithium hydroxide monohydrate (68 mg, 1.62 mmol) was
added to a stirred solution of ester 65 (70 mg, 0.054 mmol) in
THF (12 ml), methanol (1.2 ml) and water (1 ml) at rt. The
mixture was stirred at 45 ꢁC for 18 h. It was cooled to rt and
a mixture of petrol/ether (1:1, 10 ml) and then sat aq ammo-
nium chloride (10 ml) was added and the mixture was acidified
to pH 1 by dropwise addition of 5% HCl. Further petrol/ether
(1:1, 20 ml) was added and extracted. The aq layer was re-
extracted with petrol/ether (1:1, 2ꢃ20 ml). The combined or-
ganic layers were washed with water (15 ml), dried and the
solvent was evaporated. Chromatography eluting with petrol/
ethyl acetate (7:2) gave a white solid, (R)-2-{(R)-1-hydroxy-16-
[(1R,2S)-2-((R/S)-20-methyl-19-oxo-octatriacontyl)cycloprop-
yl]exadecyl}hexacosanoic acid 66 (54 mg, 81%), mp 70–72 ꢁC,
1747, 1467, 1372, 1236, 1024, 721 cmꢀ1
.
3.1.54. (R)-2-((R)-1-Hydroxy-16-{(1R,2S)-2-[(19S,20S)-20-methyl-
19-(tetrahydropyran-2-yloxy)octatriacontyl]cyclopropyl}hexa-
decyl)hexacosanoic acid 69. Lithium hydroxide monohydrate
(106 mg, 2.47 mmol) was added to a stirred solution of ester 68
½
a 2D6
ꢂ
þ4.4 (c 1.02, CHCl3) {Found (MþNa)þ: 1260.12,
C84H164NaO4 requires: 1260.25; Found: C, 81.94; H, 13.24,
C84H164O4 requires: C, 81.48; H, 13.35}. This showed dH: 3.74–

10228
G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
methyloctatriacontyl)cyclopropyl]hexadecyl}hexacosanoic
(225 mg, 0.149 mmol) in THF (10 ml), methanol (1.5 ml) and water
(1.0 ml) at rt. The mixture was stirred at 45 ꢁC for 16 h, then cooled
to rt and diluted with petrol/ethyl acetate (5:2, 25 ml) and acidified
with 2 M HCl to pH 2–3. The aqueous layer was washed with petrol/
ethyl acetate (5:2, 3ꢃ20 ml). The combined organic layers were
washed with water (20 ml), dried and evaporated. Chromatography
eluting with 7:2 petrol/ethyl acetate gave a white semi-solid,
(R)-2-((R)-1-hydroxy-16-{(1R,2S)-2-[(19S,20S)-20-methyl-19-(tetra-
hydropyran-2-yloxy)octatriacontyl]cyclopropyl}hexadecyl)hexa-
cosanoic acid 69 as a mixture of diastereoisomers (130 mg, 60%)
{Found (MþNa)þ: 1346.3253; C89H174NaO5 requires: 1346.3319}.
This showed dH: 4.67 (1H, br t, J 3.15 Hz), 4.64 (1H br.t, J 2.85 Hz),
3.97–3.88 (2H, m), 3.74–3.70 (2H, m), 3.52–3.43 (4H, m,), 2.47 (2H,
br.pent, J 4.75 Hz), 1.87–1.79 (4H, m), 1.77–1.05 (306H, m), 0.89
(12H, t, J 6.65), 0.84 (6H, d, J 6.65 Hz), 0.69–0.62 (4H, m), 0.57 (2H,
br.dt, J 4.1, 8.55 Hz), ꢀ0.33 (2H, br.q, J 5.05 Hz); nmax: 2920, 2851,
acidasawhite semi-solid (60 mg, 0.044 mmol, 60%), ½a D25
ꢀ2.06
ꢂ
(c 0.68, CHCl3) {Found (MþNa)þ: 1376.3600, C90H180NaO4Si
requires: 1376.3543}. This showed dH: 3.87 (1H, br.q, J 5.4 Hz)
3.53–3.48 (1H, br.pent,
J 3.75 Hz), 2.53 (1H, br.pent, J
5.05 Hz), 1.70–1.60 (1H, m), 1.59–1.52 (2H, m), 1.51–1.09
(146H, m), 0.91 (9H, s), 0.89 (6H, t, J 7 Hz), 0.86 (3H, d, J
7.0 Hz), 0.68–0.62 (2H, m), 0.57 (1H, br. dt, J 4.05, 8.15 Hz),
0.12 (3H, s), 0.10 (3H, s), ꢀ0.33 (1H, br. q, J 5.05 Hz); dC
:
177.11, 75.23, 73.56, 50.66, 38.16, 35.03, 34.48, 33.36, 31.93,
30.22, 29.96, 29.76, 29.71, 29.66, 29.65, 29.58, 29.52, 29.5,
29.42, 29.36, 29.06, 28.72, 27.53, 27.42, 26.27, 25.73, 24.65,
22.69, 17.94, 15.77, 14.10, 13.57, 10.91, ꢀ4.31, ꢀ4.92; nmax
3400, 3058, 2923, 2852, 2682, 1709, 1465, 1362, 1254, 1077,
1006, 970, 939, 908, 836, 811, 775 cmꢀ1
:
.
(ii) The above acid (60 mg, 0.044 mmol) in dichloromethane (2 ml)
was added in portions to a stirred solution of PCC (50 mg,
0.232 mmol) in dichloromethane (2 ml) at rt. After 2 h, it was
diluted with petrol/ethyl acetate (20 ml, 10:1), filtered over
Celite and evaporated. Chromatography (10:1 petrol/ethyl
acetate) gave (R)-2-{(R)-1-(tert-butyldimethylsilanyloxy)-16-
[(1R,2S)-2-((S)-20-methyl-19-oxo-octatriacontyl)cyclopropyl]-
hexadecyl}hexacosanoic acid 71 as a white semi-solid (44 mg,
1682, 1465, 1378, 1216, 1132, 1077, 1024, 869 cmꢀ1
.
3.1.55. (R)-2-((R)-1-(tert-Butyldimethylsilanyloxy)-16-{(1R,2S)-2-
[(19S,20S)-20-methyl-19-(tetrahydropyran-2-yloxy)octatriacontyl]-
cyclopropyl}-hexadecyl)hexacosanoic acid 70. Imidazole (65 mg,
0.96 mmol) was added with stirring to hydroxyacid 69 (125 mg,
0.096 mmol) in dry DMF (1 ml) and toluene (1.5 ml) at rt, followed
by the addition of tert-butyldimethylsilylchloride (143 mg,
0.955 mmol) and 4-dimethylaminopyridine (10 mg, 0.082 mmol),
then heated to 70 ꢁC for 18 h. The solvent was removed under high
vacuum and the residue diluted with petrol/ethyl acetate (1:1)
(30 ml) and satd aq NaHCO3 (5 ml); the organic layer was separated
and the aqueous layer was re-extracted with petrol/ethyl acetate
(3ꢃ15 ml). The combined organic layers were washed with water,
dried and evaporated. The residue was dissolved in THF (10 ml),
water (1.5 ml), and methanol (1.5 ml) and potassium carbonate
(150 mg) were added, stirred at 45 ꢁC for 6 h, then diluted with
petrol/ethyl acetate (10:1, 20 ml) and water (2 ml) and acidified to
pH 2 with potassium hydrogen sulfate. The organic layer was
separated and the aqueous layer was re-extracted with petrol/ethyl
acetate (2ꢃ20 ml). The combined organic layers were washed with
water, dried and evaporated. Chromatography eluting with petrol/
ethyl acetate (20:1) gave a white semi-solid, (R)-2-((R)-1-(tert-
butyldimethylsilanyloxy)-16-{(1R,2S)-2-[(19S, 20S)-20-methyl-19-
(tetrahydropyran-2-yloxy)octatriacontyl]cyclopropyl}hexadecyl)-
hexacosanoic acid 70 as a mixture of diastereoisomers (104 mg,
76%) {Found (MþNa)þ: 1460.4118, C95H188NaO5 requires: 1460.
4064}. This showed dH: 4.66 (1H, br., t, J 3.15 Hz), 4.63 (1H, br., t, J
4.45 Hz), 3.86–3.94 (2H, m), 3.86–3.82 (2H, m) 3.52–3.43 (4H, m),
2.53 (2H, ddd, J 3.15, 5.95, 9.15 Hz), 1.89–1.79 (4H, m), 1.75–1.03
(304H, m), 0.93 (18H, s), 0.89 (12H, t, J 6.65 Hz), 0.85 (6H, d, J
6.9 Hz), 0.68–0.62 (4H, m), 0.56 (2H, br. dt., J 4.1, 8.15 Hz), 0.15 (6H,
s), 0.13 (6H, s), -0.33 (2H, br.q, J 5.05 Hz); nmax: 2924, 1708, 1466,
74%), ½a 2D5
ꢂ
þ5.18 (c 0.83, CHCl3) {Found (MþNa)þ: 1374.3387,
C90H178NaO4Si requires: 1374.3367}; dH: 3.87 (1H, br., q, J
5.05 Hz), 2.51 (2H, m), 2.42 (2H, dt, J 2.2, 7.25 Hz),1.72–1.60 (2H,
m), 1.59–1.53 (4H, m), 1.51–1.10 (139H, m) 1.06 (3H, d, J 7.0 Hz)
0.92 (9H, s), 0.89 (6H, t, J 7.0 Hz), 0.69–0.63 (2H, m), 0.57 (1H, br.,
dt, J 4.1, 8.5 Hz), 0.12 (3H, s), 0.10 (3H, s), ꢀ0.33 (1H, br., q, J
5.05 Hz); dC: 215.18, 176.43, 73.63, 50.44, 46.34, 41.15, 35.34,
33.05, 31.94, 30.22, 29.69, 29.67, 29.63, 29.60, 29.55, 29.51,
29.49, 29.46, 29.41, 29.36, 29.33, 28.72, 27.48, 27.32, 25.73,
24.82, 23.71, 22.68, 17.93, 16.35, 15.76, 14.10, 10.91, ꢀ4.29, 4.92;
nmax: 2924, 2853,1709, 1464,1363,1254,1216,1078, ꢀ939, 836,
760, 721, 667 cmꢀ1
.
3.1.57. (R)-2-{(R)-1-Hydroxy-16-[(1R,2S)-2-((S)-20-methyl-19-oxo-
octatriacontyl)cyclopropyl]hexadecyl}hexacosanoic acid 72. A dry
polyethylene vial equipped with a rubber septum was charged with
acid 71 (44 mg, 0.0325 mmol) and pyridine (100
(4 ml) and stirred at rt under nitrogen and hydrogen fluoride-pyr-
idine complex (230
L, 70:30) was added. After 13 h at 42 ꢁC, it was
mL) in dry THF
m
diluted with petrol/ethyl acetate (10 ml, 1:1) and neutralized by
pouring into satd aq sodium bicarbonate. The aqueous layer was re-
extracted with petrol/ethyl acetate (3ꢃ15 ml, 1:1). The combined
organic layers were washed with brine, dried and evaporated.
Chromatography (7:2 petrol/ethyl acetate) gave a white solid, (R)-
2-{(R)-1-hydroxy-16-[(1R,2S)-2-((S)-20-methyl-19-oxo-octa-tri-
acontyl)cyclopropyl]hexadecyl}hexacosanoic acid 72 (33 mg, 83%),
1255, 1024, 836, 775 cmꢀ1
.
½
a 2D6
ꢂ
þ7.34 (c¼0.79, CHCl3), mp 66–68 ꢁC {Found (MþNa)þ:
1260.2522, C84H164NaO4 requires: 1260.2568}. This showed; dH
:
3.1.56. (R)-2-{(R)-1-(tert-Butyldimethylsilanyloxy)-16-[(1R,2S)-2-
((S)-20-methyl-19-oxo-octatriacontyl)cyclopropyl]hexadecyl}-
hexacosanoic acid 71.
3.72 (1H, br., pent, J 4.7 Hz), 2.52 (1H, q, J 6.6 Hz), 2.48 (1H, m), 2.42
(2H, dt, J 1.85, 7.25 Hz), 1.78–1.70 (1H, m), 1.67–1.60 (2H, m), 1.59–
1.46 (6H, m), 1.4–1.10 (137H, m), 1.05 (3H, d, J 6.95 Hz), 0.89 (6H, t, J
7.25 Hz), 0.71–0.62 (2H, m), 0.56 (1H, br.dt, J 4.1, 8.5 Hz), ꢀ0.33 (1H,
br.q, J 5.00 Hz); dC: 215.42, 179.80, 72.12, 50.86, 46.33, 41.15, 35.51,
33.04, 31.92, 30.23, 29.71, 29.66, 29.52, 29.50, 29.47, 29.43, 29.37,
29.33, 28.73, 27.33, 25.73, 23.73, 22.69, 16.35, 15.78, 14.11, 10.91,
(i) Pyridinium-p-toluenesulfonate (100 mg, 0.40 mmol) was
added to (R)-2-((R)-1-(tert-butyldimethyl-silanyloxy)-16-{(1R,
2S)-2-[(19S,20S)-20-methyl-19-(tetrahydropyran-2-yloxy)-
octatriacontyl]cycloprop-yl}hexadecyl)hexacosanoic acid 70
(100 mg, 0.07 mmol) in THF (4 ml), MeOH (0.5 ml) and H2O
(0.2 ml) and stirred at 47 ꢁC for 7 h. Satd aq sodium bi-
carbonate (3 drops) was added and the product was extracted
with petrol/ethyl acetate (3ꢃ15 ml, 1:1). The combined organic
layers were dried and evaporated. Chromatography eluting
with 10:1 petrol/ethyl acetate gave (R)-2-{(R)-1-(tert-butyldi-
methyl-silanyloxy)-16-[(1R,2S)-2-((19S,20S)-19-hydroxy-20-
nmax: 3284, 2919, 2850, 1708, 1465, 1377, 721 cmꢀ1
.
Supplementary data
The supplementary data associated with this article can be
found in the on-line version at doi:10.1016/j.tet.2009.09.099.

G. Koza et al. / Tetrahedron 65 (2009) 10214–10229
10229
19. Rao, V.; Gao, F.; Chen, B.; Jacobs, W. R.; Glickman, M. S. J. Clin. Immunol. 2006,
116, 1660–1666.
References and notes
20. Al Dulayymi, J. R.; Baird, M. S.; Roberts, E. Chem. Commun. 2003, 228–229;
Tetrahedron 2005, 61, 11939–11951.
21. Al Dulayymi, J. R.; Baird, M. S.; Roberts, E.; Minnikin, D. E. Tetrahedron 2006, 62,
11867–11880.
22. Al Dulayymi, J. R.; Baird, M. S.; Roberts, E.; Deysel, M.; Verschoor, J. Tetrahedron
2007, 63, 2571–2592.
23. Al-Dulayymi, J. R.; Baird, M. S.; Mohammed, H.; Roberts, E.; Clegg, W. Tetra-
hedron 2006, 62, 4851–4862.
1. Minnikin, D. E. In The biology of the mycobacteria; Standford, J., Ed.; Academic:
San Diego, CA, 1982; pp 95–184.
2. Barry, C. E.; Lee, R. E.; Mdluli, K.; Sampson, A. E.; Schoeder, B. G.; Slayden, R. A.;
Yuan, Y. Prog. Lipid Res. 1998, 37, 143–179.
3. Watanabe, M.; Aoyagi, Y.; Ridell, M.; Minnikin, D. E. Microbiology 2001, 147,
1825–1837.
4. Watanabe, M.; Aoyagi, Y.; Mitome, H.; Fujita, T.; Naoki, H.; Ridell, M.; Minnikin,
D. E. Microbiology 2002, 148, 1881–1902.
24. Koza, G.; Baird, M. S. Tetrahedron Lett. 2007, 48, 2165–2169.
25. Baudin, J. B.; Hareau, G.; Julia, S. A.; Ruel, O. Tetrahedron Lett. 1991, 32 1175-1178;
Blakemore, J. R.; Kocienski, P. J.; Marzcak, S.; Wicha, J. Synthesis 1999,1209–1215;
Smith, N. D.; Kocienski, P. J.; Street, S. D. A. Synthesis 1996, 652–666.
26. Kopecky, D. J.; Rychnovsky, S. D. J. Am. Chem. Soc. 2001, 123, 8420–8421.
27. Graetz, B. R.; Rychnovsky, S. D. Org. Lett. 2003, 5, 3357–3359.
28. Loubinoux, B.; Sinnes, J.-L.; O’Sullivan, A. C.; Winkler, T. Tetrahedron 1995, 51
3549–3558.
29. Brooks, D. W.; Kellogg, R. P.; Cooper, C. S. J. Org. Chem. 1987, 52, 192–196.
30. Toschi, G.; Baird, M. S. Tetrahedron 2006, 62, 3221–3227.
31. Frater, G.; Muller, U.; Gunther, W. Tetrahedron 1984, 40, 1269–1277; Frater, G.
Tetrahedron Lett. 1981, 22, 425–428.
32. Su, Q.; Dakin, L. A.; Panek, J. S. J. Org. Chem. 2007, 72, 2–24.
33. Matsuura, F.; Peters, R.; Anada, M.; Harried, S. A.; Hao, J.; Kishi, Y. J. Am. Chem.
Soc. 2006, 128, 7463–7465.
34. Krishna, P. R.; Reddy, V. V. R. Tetrahedron Lett. 2005, 46, 3905–3908.
35. Sugimoto, T.; Ishihara, J.; Murao, A. Synlett 1999, 541–544.
36. Behr, M. A.; Schroeder, B. G.; Brinkman, J. N.; Slayden, R. A.; Barry, C. E.
J. Bacteriol. 2000, 182, 3394–3399.
5. Heath, R. J.; White, S. W.; Rock, C. O. Appl. Microbiol. Biotechnol. 2002, 58,
695–703.
6. Minnikin, D. E.; Polgar, N. J. Chem. Soc., Chem. Commun. 1966, 648–649; Min-
nikin, D. E.; Polgar, N. Tetrahedron Lett. 1966, 2643–2647.
7. Asselineau, C.; Tocanne, G.; Tocanne, J. F. Bull. Soc. Chim. Fr. 1970, 4, 1455–1459;
Asselineau, C.; Asselineau, J. Bull. Soc. Chim. Fr. 1966, 1992–1999; Tocanne, J. F.;
Asselineau, C. Bull. Soc. Chim. Fr. 1968, 4519–4525.
8. Lacave, C.; Lane´elle, M.-A.; Montrozier, H.; Rols, M.-P.; Asselineau, C. Eur. J.
Biochem. 1987, 163, 369–378.
9. Daffe´, M.; Lane´elle, M. A.; Guillen, L. V. Eur. J. Biochem. 1988, 177, 339–340.
´
´
10. Daffe, M.; Laneelle, M. A.; Lacave, C. Res. Microbiol. 1991, 142, 397–403.
11. Durand, E.; Welby, M.; Lane´elle, G.; Tocanne, J.-F. Eur. J. Biochem.1979, 93,103–112.
12. Durand, E.;Gillois, M.; Tocanne, J.-F.; Lane´elle, G. Eur. J. Biochem.1979, 94,109–118.
13. Moody, D. B.; Guy, M. R.; Grant, E.; Cheng, T.-Y.; Brenner, M. B.; Besra, G. S.;
Porcelli, S. A. J. Exp. Med. 2000, 192, 965–976.
14. Watanabe, R.; Yoo, Y. C.; Hata, K.; Mitobe, M.; Koike, Y.; Nishizawa, M.; Garcia,
D. M.; Nobuchi, Y.; Imagawa, H.; Yamada, H.; Azuma, I. Vaccine 1999, 17,
1484–1492.
15. Que´mard, A.; Lane´elle, M. A.; Marrak-chi, H.; Prome´, D.; Daffe´, M. Eur. J. Bio-
chem. 1997, 250, 758–763.
16. Laval, F.; Laneelle, M.-A.; Deon, C.; Monsarrat, B.; Daffe, M. Anal. Chem. 2001, 73,
4537–4544.
17. Yuan, Y.; Qi, Z.; Crane, D. D.; Barry, C. E. Mol. Microbiol. 1998, 29, 1449–1458.
18. Dubnau, E.; Chan, J.; Raynaud, C.; Mohan, V. P.; Laneelle, M. A.; Yu, K. M.;
Quemard, A.; Smith, I.; Daffe, M. Mol. Microbiol. 2000, 36, 630–637.
37. Dubnau, E.; Lane´elle, M. A.; Soares, S.; Benichou, A.; Vaz, T.; Prome´, D.; Prome´,
´
´
J.-C.; Daffe, M.; Quemard, A. Mol. Microbiol. 1997, 23, 313–322.
38. We thank Prof. D.E.Minnikin (Univ. of Birmingham) for providing samples of
natural ketomycolic acid fractions.
39. Thanks are due to Mr B.Grail, School of Biological Sciences, Bangor for running
these spectra.